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Abstract 
 
Frisky Dienes and Hot Electrophiles 
Development of synthetic methods to access key structural features of tetrapetalone A 
 
by 
 
Marisa Gail Weaver 
 
 
 
The tetracyclic natural product, tetrapetalone A has eluded chemists since its isolation in 
2002. The complex structural features of this natural product provide a platform from which 
new synthetic methods can be developed. One approach to build tetrapetalone includes 
formation of a Nitrogen-Aryl bond. Despite the prevalence of this bond connection in 
natural and pharmaceutical compounds, previous methods to form Nitrogen-Aryl bonds 
were not applicable in our approach to the tetrapetalone A scaffold. To overcome this 
limitation and provide a different route to access compounds containing Nitrogen-Aryl 
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bonds, we approached the problem with a different strategy. This divergent strategy relies 
upon distinct deprotonation conditions of a cyclic vinylogous amide to afford regioisomeric 
dienes. Each diene can then undergo a tandem Diels-Alder and retro-Diels-Alder sequence 
with a variety of acetylenic dienophiles to afford a range of multi-substituted aromatic 
products containing Nitrogen-Aryl bonds. The scope of this method and its application 
toward tetrapetalone A will be discussed. While investigating different synthetic approaches, 
our group also probed the reactivity of the tetramic acid C-5 position. When our group 
encountered limitations among the current methods to install vinyl groups at the C-5 
position we turned to develop a more general vinylation strategy. Our progress toward a 
"vinylation reagent" is reported and future directions will be discussed. 
  xii 
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Chapter 1: The Tetrapetalones 
 
  
  2 
1.1 Tetrapetalone A 
Tetrapetalone A is a soybean lipoxygenase (SBL) inhibitor isolated from the culture 
filtrate of the Streptomyces sp. USF-4727 strain in 2002.1 The natural product was initially 
assigned incorrectly. However, further NMR analysis using 1H-15N HMBC, NOE analysis 
and chemical derivatization techniques prompted structural reassignment to 1 in 2003 (see 
Figure 1).2 
Figure 1: Structures of the Tetrapetalones 
 
Tetrapetalone A (1) is in family of compounds that also includes tetrapetalones B (2), C 
(3), and D (4).3 Tetrapetalone A is a biologically interesting synthetic target because it has 
shown inhibition against soybean lipoxygenase (IC50=190-360 µM). Lipoxygenase 
inhibitors have been found to inhibit leukotrienes that are important for human allergy, 
asthma and arthritis treatments.4 Lipoxygenase inhibitors may also play a role in the process 
by which human prostate cancer cells suffer apoptosis.5 As a lipoxygenase inhibitor, 
tetrapetalone A has potential therapeutic applications in a variety of diseases. 
The biosynthetic pathway of the tetrapetalones was studied using feeding experiments by 
Komoda et al.6 The feeding experiments were conducted using isotope labeled [1-13C] 
sodium propanoate, [1-13C] sodium butanoate, [carbonyl-13C] 3-amino-5-hydroxybenzoic 
acid hydrochloride, and [1-13C] glucose. To identify where these fragments were 
incorporated, the 13C isotope enrichment sites of the product were analyzed. Tetrapetalone A 
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(1) required three molecules of propanoate, one of butanoate, and one molecule of 3-amino-
5-hydroxybenzoic acid to be constructed by polyketide synthase (PKS) (see Figure 2).  
Figure 2: Biosynthetic Feeding Experiments 
 
These feeding experiments also revealed the biosynthetic relationship of the 
tetrapetalone family. Tetrapetalone A (1) can be oxidized to form tetrapetalones B (2) or C 
(3), and tetrapetalone B (2) can be oxidized to form tetrapetalone D (4). Separate from the 
interesting biological activity of the tetrapetalones, their tetracyclic skeleton provides many 
opportunities to develop new synthetic methods. The unique architecture of the 
tetrapetalones has attracted the attention of many synthetic chemists since it was isolated. 
1.2 Synthetic Attempts to Build Tetrapetalone A 
Porco’s Strategy 
Shortly after tetrapetalone A was isolated, Porco attempted to synthesize the natural 
product using an approach that was inspired by the similarities that the tetrapetalones share 
with the ansamycin antibiotics.7 Porco’s synthetic approach aimed to build tetrapetalone A 
through a transannular [4 + 3] cyclization of 5 to form the B, C and D rings (see Scheme 1).  
Scheme 1: Porco's Key Retrosynthetic Step 
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Porco's group aimed to intercept the macrocylce 5 for their key [4+3] transannular 
cyclization step. They envisioned that this intermediate could be reached by an acyl transfer 
in the meta-hydroxyaniline 6 which would be obtained by reduction of the aryl nitro group 
in compound 7. Porco’s group envisioned starting their synthesis to obtain compound 7 by 
the macrolactonization and metathesis of 8 and 9. Their first characterization of the reaction 
product led them to believe that their desired cyclized product was formed. However, further 
investigation showed that the oxidative their group isolated was just the para-quinone 10 
(see Figure 3).8 
Figure 3: Porco's Corrected Product 
 
Li's Strategy to Build Benzazepines 
A method for preparation of the carbon skeleton of the tetrapetalones was developed in 
2009.9 Li et al. prepared the core benzazepine 11 starting from the nitro-styrene 15 (see 
Scheme 2).  
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Scheme 2: Synthesis of the Benzazepines 
 
The B-ring of the tetracyclic core in compound 11 was obtained by addition of 
polyphosphoric acid to break the tethered γ-lactone in compound 12 and promote the 
electrophilic aromatic substitution of the acid tether with the aromatic ring. The tetracycle 
12 was obtained from compound 13. Compound 13 was obtained by addition of ethyl 
orthoacetate to compound 14 followed by a Claisen rearrangement and further elaboration of 
the nitro-group. Although this method provided the core tetracyclic carbon skeleton (11) of 
the tetrapetalones, it is missing some key components. This includes the fully elaborated 
electron-withdrawing tetramic acid D-ring and functional handles to elaborate into the 
quinol and to glycosylate the five-membered ring. 
Sarpong’s Strategy 
Sarpong's synthetic route was focused around using a reductive pyrrole alkylation (see 
Scheme 3).10 
Scheme 3: Sarpong's Retrosynthetic Strategy 
 
Sarpong envisioned the preparation of 15 by using a reductive alkylation to install the 
angular ethyl group from the acylated pyrrole 16. Reduction and further derivatization of 17 
would yield the pyrrole. Compound 17 would be prepared by Nazarov cyclization of 18 
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followed by lithium-halogen exchange installed the corresponding azide. To begin, the bis-
bromoanisole 20 and Weinreb amide 19 would be coupled using n-butyllithium to afford the 
dienone 18. Although Sarpong obtained intermediate 15, the group abandoned this synthetic 
route when they determined that their tetracycle 15 could not be further functionalized into 
the final natural product. 
Frontier's Strategy 
The tetrapetalones still have yet to be synthesized, but Frontier's strategy has been the 
closest published attempt and has provided good evidence to confirm the structure of the 
natural product.11 Frontier's strategy affords the tetrapetalone A-Me aglycon (21) in less than 
30 steps from 3-bromo-5-iodo-phenol (see Scheme 4).  
Scheme 4: Frontier's Retrosynthetic Strategy 
 
Frontier’s strategy incorporates an oxidative dearomatization of intermediate 22, which 
was obtained by a diastereoselective ring-closing metathesis of 23. The tricycle 23 was 
obtained by elaboration of the aniline nitrogen in compound 24 into the C-3 tetramic acid. 
The nitrogen was incorporated into the core structure through a palladium-cross-coupling 
reaction of 25 with ammonia. Compound 24 was formed by a Nazarov cyclization, similar 
to the strategy used by Sarpong.10 A Negishi cross-coupling reaction with the known phenol 
26, followed by a subsequent [3+2] reaction with an unsaturated nitrone afforded compound 
25. Despite the multitude of efforts and the thirteen years dedicated to synthesize the 
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tetrapetalones, none of the isolated members in the natural product family have been 
synthesized.  
1.3 Difficulties Associated with Construction of Tetrapetalone A 
With many incomplete syntheses over the past twelve years, our group knew that the 
synthesis of tetrapetalone A would be a challenge. Nevertheless, we decided to approach the 
target by breaking it into separate pieces. We envisioned developing the chemistry 
surrounding each of these pieces to understand the reactivity and gain insight to form the 
most effective strategy to build tetrapetalone A while developing new methods (see Figure 
4). 
Figure 4: Key Structural Features of Tetrapetalone A 
 
The first challenge would be to synthesize a compound containing the Nitrogen-Aryl 
bond. Our aim was to do this in such a fashion that would incorporate functional handles 
that could be used later to build the five- and seven-membered rings in the tetracycle. Due to 
the rare occurrence of the C-3 methyl tetramic acids, the second challenge was to construct a 
model tetramic acid moiety and then work towards understanding the chemistry surrounding 
this group. Lastly, previous attempts in our group to install an ethyl group at the C-5 
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position proved difficult with current methods. We envisioned developing a general and 
mild reagent to incorporate vinyl groups in a facile manner, that could be applied to install 
the ethyl group in the synthesis of tetrapetalone A. 
1.4 Pettus’ Retrosynthetic Analysis 
In our approach to Tetrapetalone A, we envisioned synthesizing the natural product from 
the aromatized intermediate 27 (see Scheme 5).  
Scheme 5: Pettus’ Retrosynthetic Strategy 
 
Intermediate 27 would contain the fully functionalized tetramic acid and be appended to 
an aromatic core containing the key nitrogen-aryl bond. To form this intermediate, we 
thought that functional handles could be incorporated onto the aromatic ring and the tetramic 
acid moiety in compound 28 that would allow for the elaboration into the five- and seven-
membered rings of the natural product. In the final steps, we aimed to install a vinyl group 
using a mild method that could be reduced into the corresponding angular ethyl group on the 
route to the elusive tetrapetalone A (1). 
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2.1 Nitrogen-Aryl Bonds in Natural and Synthetic Compounds 
Compounds containing nitrogen-aryl bonds are prevalent in a variety of natural and 
synthetic products that have implications in helping treat disease or are currently being used 
as FDA-approved pharmaceuticals. Cardiovascular disease is responsible for 1 in 4 deaths 
that occur in the United States, so much of the spending on health care is directed toward 
treatment of this disease.12 In 1996, health costs related to this disease totaled $157 billion 
dollars.13 This amount had already doubled by 2008 to $301 billion dollars and is expected 
to continue to rise. A recent analysis by the Njardson group shows that 40% of the FDA-
approved cardiovascular treatments contain nitrogen-aryl bonds.14 A more commonly used 
drug containing a nitrogen-aryl bond is acetominophen, the active ingredient in Tylenol. 
Despite the prevalence of this bond connection in natural and synthetic pharmaceutical 
compounds, the current methods that exist do have weaknesses. The applications of known 
methods to the tetrapetalone A scaffold in our strategy are limited. 
2.2 Weaknesses of the Nitrogen-aryl Bond Disconnection 
A common theme in the previous synthetic approaches to tetrepetalone A is that the 
nitrogen heteroatom has not been incorporated as the fully elaborated tetramic acid core 
moiety. Instead, the tetramic acid has been installed by incorporating a nitro-group that was 
further reduced, using an azide, or cross-coupling of an aryl halide with ammonia. The 
aniline cores were then elaborated to the C-3 methyl tetramic acid that is characteristic of the 
tetrapetalones. This post-functionalization approach adds steps and can make it difficult to 
elaborate intermediates to the final core concisely.  
Even with the advances of the palladium-mediated cross-coupling reactions, specifically 
the Büchwald-Hartwig amination reaction, this approach is not general. When applied in 
  11 
previous attempts to synthesize tetrapetalone by Frontier's group, many palladium-mediated 
cross-coupling approaches were tried, but resulted in dead-ends or failure.15 In the literature, 
it is difficult to find examples of cross-coupling reactions between partners containing 
functional group tethers that could be elaborated to build tetrapetalone A. Results that were 
reported strongly suggested that a cross-coupling approach to form the nitrogen-aryl bond 
connection would be very limited. 
In the cross-coupling reaction between ethyl 4-bromobenzoate 29 and the pyrrolidinone 
30, the reaction affords the product was afforded in 91% yield in only 8 hours (see Scheme 
6).16 
Scheme 6: Büchwald-Hartwig Amination of 29 
 
However, when the electron-withdrawing group on the aryl bromide is shifted to the 
meta-position, the cross-coupling reaction essentially does not proceed (see Scheme 7). 
Scheme 7: Cross-Coupling Reaction with Aryl Bromide 32 
 
The reaction with the meta-substituted methyl ester 32a proceeds to give the product 33a 
in only 5% yield, and the meta-substituted aldehyde 32a does not yield any of the expected 
product 33b. These cross-coupling reactions were carried out under similar conditions and 
with the same lactam nucleophile (30) previously reported to work with the para-substituted 
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aryl halide (see Scheme 6). However, changing the substitution pattern of the electron-
withdrawing group and moving it closer to the C-X bond severely thwarted the desired 
reaction. 
There are limited examples of the Büchwald-Hartwig cross-coupling reaction with an 
aromatic coupling partner containing any substitutents in the ortho- or meta- position 
relative to the C-X bond are severely limited. Many of these representative examples of this 
cross-coupling reaction type are extremely ineffective. With the same electron-deficient 
lactam nucleophile 30, the cross-coupling reaction with bromobenzene 34 also failed to 
proceed satisfactorily and furnished the coupled product in only a 15% yield (see Scheme 8). 
Scheme 8: Cross-Coupling of Bromobenzene with 30 
 
If a more nucleophilic nitrogen coupling partner, like a secondary alkyl amine, is 
coupled with para-chlorobenzonitrile 36, the reaction also fails to proceed efficiently and 
the product 35 is only formed in a 23% yield (see Scheme 9).17 
Scheme 9: Cross-Coupling of 36 with di-Hexyl Amine 
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methoxychlorobenzene 38 with aniline, the reaction only proceeds in 10% yield after 32 
hours (see Scheme 10).18 
Scheme 10: Cross-coupling of 38 with Aniline 
 
Presumably, the inefficiency of this example is related to the C-Cl bond strength due to 
the resonant donation effect of the methoxy group. 
These examples demonstrate that current methods to couple aryl halides possessing 
electron-donating or electron-withdrawing substituents in the ortho- or meta- position with a 
nitrogen coupling partner are inefficient. Furthermore, the use of nitrogen coupling partners 
that are electron-deficient is ineffective. These examples show that attempting to construct 
the nitrogen-aryl bond in tetrapetalone A through a palladium-mediated cross-coupling 
approach with an elaborated tetramic acid nucleophile would likely be unsuccessful. Since 
our synthetic strategy required an intermediate containing a tetramic acid moiety appended 
to an elaborated aromatic ring, we were challenged to develop a different method. To 
overcome the limitation of the cross-coupling strategy, the work of Danishefsky and Reusch 
provided good inspiration.  
2.3 Previous Work 
Danishefsky had previously used dienes derived from 1,3-cyclohexadiones to study their 
reactivity and for their application in total syntheses.19 These synthesized dienes were often 
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(diene 40 and 41), but some have been used with differing R and R1 groups (diene 42 and 
43) (see Scheme 11). 
Scheme 11: Danishefsky's Application of 1,3-Cyclohexadione Derived Dienes 
 
Danishefsky showed that dienes of this nature were shown to undergo a tandem Diels-
Alder and retro-Diels-Alder reaction to afford tetra-substituted aromatic materials 
represented by compound 44. The substitutents of the dienophiles (-EWG and -R2) could be 
outfitted in a variety of different ways to provide synthetic handles and allowed for 
elaboration of the aromatic intermediates into synthetic targets. The ability to form these 
dienes was rooted in deprotonation studies published decades ago. 
In 1976, d’Angelo published a compilation of methods where ketone enolates with a 
variety of different substituents could be prepared regioselectively by differing 
deprotonation methods.20 He highlighted the work by Reusch that demonstrated that the 
cyclic vinylogous amide (CVA) 45 could be selectively deprotonated to form either the 
thermodynamic enolate 46 or the kinetic enolate 47 (see Scheme 12).21 
Scheme 12: Regioselective Deprotonation of CVA 45 
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This work showed that in the presence of an excess of the CVA 45, the thermodynamic 
enolate 46 (fully conjugated with oxygen) was formed and alkylated at the gamma-position 
to form 48 upon quenching with methyl iodide. In the presence of excess base, the kinetic 
enolate 47 (cross-conjugated with oxygen) formed and upon quenching with methyl iodide, 
the material was preferentially methylated at the alpha-site to yield compound 49. 
The work done by both Danishefsky and Reusch inspired us to develop a Diels-Alder 
method to form compounds containing a nitrogen-aryl bond from simple 1,3-cyclohexadione 
derived vinylogous amide starting materials. We envisioned that regioselective 
deprotonation events with the CVA would allow access to two classes of regiodifferentiated 
tetra-substituted aromatic products. This idea remained unexplored and had only been 
briefly been investigated by Carter.22 
2.4 Nitrogen-Aryl Bond Construction Through a Diels-Alder Strategy 
Our approach aimed to develop a divergent strategy that would rely upon distinct 
deprotonation conditions of a cyclic vinylogous amide and afford regioisomeric 
thermodynamic and kinetic dienes. We envisioned that each diene would then undergo a 
tandem Diels-Alder (DA) and retro-Diels-Alder (r-DA) sequence with a variety of 
acetylenic dienophiles to afford a range of multi-substituted regioisomeric aromatic products 
containing nitrogen-aryl bonds (see Figure 5).23  
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Figure 5: Diels-Alder Strategy to Construct Nitrogen-Aryl Bonds 
 
We envisioned that this method would not only allow us access to highly substituted 
compounds containing nitrogen-aryl bonds which are not generally accessible by current 
Büchwald-Hartwig amination reaction conditions, but would also allow access to the meta-
amino phenol scaffold (highlighted in blue) present in a variety of natural and synthetic 
products. This includes products like the iron-binding siderophore pyoverdine,24 the 
therapeutic treatment murrazoline25 and anti-tumor agents such as geldanamycin.26 
2.5 Synthesis of a Model CVA System 
To develop and probe the scope of our method, the model core systems 50a-c were 
synthesized starting from simple commercially available materials (see Scheme 13). 
Scheme 13: Synthesis of Model CVA Systems 50a-c 
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The commercially available and inexpensive 1,3-cyclohexadiones were used to prepare 
50a-c in a short two-step procedure. The acid-catalyzed condensation reaction with benzyl 
amine afforded an enamine that was deprotonated with n-butyllithium and added to benzyl 
chloroformate to furnish the model systems in good yields. 
2.6 Regioselective Deprotonation of CVA Systems 
The three model core systems were submitted to our two separate regioselective 
deprotonation events to yield the corresponding thermodynamic and kinetic dienes (see 
Table 1). 
Table 1: Regioselective Deprotonation Event 
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Entry CVA Thermodynamic Diene (k) Kinetic Diene (t) Ratio t:k 
1a 50a 51a 52a >20:1 
2b 50a 51a 52a 1:>10 
3a 50b 51b 52b >20:1 
4b 50b 51b 52b 1:~4 
5a 50c 51c 52c >20:1 
6c 50c 51c 52c 1:>10 
a50a (1.3 equiv.) KHMDS (1.0 equiv.), THF (0.02M), 0 °C, 5h; TBSCl (1.1 equiv.). bKOtBu (1.5 equiv.), 
nBuLi (1.5 equiv.), - 78 °C, THF (0.02M), 20 min; 50a (1.0 equiv.), 10 min; TBSCl (2.0 equiv.), - 78 °C to rt. 
cKHMDS (1.2 equiv.), THF (0.02M), - 78 °C, 50a (1.0 equiv.), 10 min; TBSCl (1.4 equiv.), - 78 °C to rt. 
 
Each of the thermodynamic dienes was formed selectively by using an excess of the 
corresponding CVAs 50a-c which allowed for equilibration and formation of the more 
stable thermodynamic enolate. Addition of tert-butydimethylsilylchloride (TBSCl) afforded 
each of the dienes 50a-c in good yield as the only product. 
Use of excess base to effect the deprotonation of 50a and 50b yielded both the kinetic 
dienes 52a and 52b almost exclusively after addition of TBSCl. In the case of 50c, 
deprotonation with excess base yielded 52c, but enriched by only 80%. After purification, 
each kinetic diene 52a-c, contained a small amount of its corresponding thermodynamic 
diene 51a-c, and was visible by NMR analysis. With these dienes in hand we proceeded to 
investigate their reactivity in our Diels-Alder and retro-Diels-Alder strategy. 
2.7 Mechanism of the Diels-Alder and retro-Diels-Alder Reaction 
The six dienes (51a-c) and (52a-c) were then subjected to our Diels-Alder and retro-
Diels-Alder reaction conditions in the presence of an acetylenic dienophile. The general 
reaction pathway for both the thermodynamic and kinetic dienes is shown below (see 
Scheme 14).  
Scheme 14: General Diels-Alder and retro-Diels-Alder Reaction Mechanism 
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First, the acetylene and diene undergo the initial Diels-Alder cycloaddition reaction to 
form the bicyclo[2.2.2]octane intermediate. This bicyclic intermediate then proceeds 
through a retro-Diels-Alder reaction to expel isobutylene, ethylene or styrene (depending on 
Y and Y') to afford the regioisomeric multi-substituted aromatic products containing the 
nitrogen-aryl bond we sought to make. With these initial studies, we determined that core 
50a was the most convenient to use. The simple dimedone starting material was the most 
inexpensive and provided the best product yields. It should be noted that dienes derived 
from core 50c allowed the Diels-Alder reaction temperature to be lowered from 150 °C to 
100 °C, but this lowered temperature was not beneficial for our goals. With our model 
system chosen, we set out to determine the reaction scopes for our dienes. 
2.7 Thermodynamic Diene Reaction Scope 
Diene 51a formed a variety of aromatic products 53-61 when subjected to the reaction 
conditions with a variety of differing acetylenes (see Scheme 15). 
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Scheme 15: Reaction Scope for Thermodynamic Diene 51a 
 
The reaction sequence with the thermodynamic diene occurred in good yield with 
acetylenic diesters (53, 54), terminal esters (55), a terminal ketone (56), and with an 
aldehyde (57). The yields were lower when more reactive acetylenes were used. This was 
the case when the halogenated propionaldehydes (58, 59), the acetylenic keto-ester (60a, 
major isomer) and ethyl cyanoformate (61) were used. Analysis of the crude spectra 
suggested that the lower reaction yields were a result of acetylene degradation. 
The reaction of diene 51a with the acetylenic keto-ester gave rise to a mixture of 
regioisomeric products 60a (pictured) and 60b (see Scheme 15). This mixture resulted 
because of the competing directing effects between the ketone and the ester on either side of 
the acetylenic dienophile. We envisioned that the ketone and ester groups added to the 
aromatic ring by the acetylene would serve as good tethers for further functionalization of 
the tetrapetalone target. We then submitted the product mixture (60a & 60b) to basic 
N
TBSO
Bn CBz
X
R
GWE
150 °C
sealed tube
benzene
12h X
N
TBSO
Bn CBz
R
EWG
9 examples
N
TBSO
Bn CBz
CO2Me
CO2Me
N
TBSO
Bn CBz
CO2CH2CF3
CO2CH2CF3
N
TBSO
Bn CBz
CO2Et
N
TBSO
Bn CBz
C(O)CH3
N
TBSO
Bn CBz
Br
CHO
N
RO
Bn CBz
Cl
CHO
N
TBSO
Bn CBz
CO2Me
C(O)Et
N
TBSO
Bn CBz
CHO
N
N
TBSO
Bn CBz
CO2Et
53a
85% yield
54a
63% yield
55a
85% yield
56a
79% yield
61d
61% yield
57b
65%yield
58c
40% yield
59c
33% yield
R = OH
60ab
2:1 ratio (60a:60b)
67% yield
OTBS
51a
Dienophile Equivalents: a 2 equivalents. b4 equivalents. cDienophile used crude without purification. d10 equivalents.
  21 
conditions in anticipation of closing the 5-membered ring in a convergent fashion (see 
Scheme 16).  
Scheme 16: Convergent Ring-Closure to Form 62 
 
The ring-closed product 62 formed upon slow addition of the substrate mixture 
(60a:60b, 2:1) to KHMDS in THF at -78 °C. With the success of this convergent ring-
closure, we anticipated that we could employ a similar strategy to access the fused 5-
membered ring in the core of tetrapetalone A while installing ketone functional handles for 
further elaboration. 
The products from the thermodynamic diene were further manipulated into other useful 
derivatives (see Scheme 17).  
Scheme 17: Formation of Anilines and Pyridones 
 
Hydrogenolysis of 53 led to tetra-substituted aniline 63 in excellent yield. Product 61 
could also be tautomerized under acidic conditions to form pyridone 64, which contains the 
carbon skeleton (highlighted in blue) of a patented migraine treatment.27 These 
manipulations show that our synthetic strategy can be used to form pyridones and anilines in 
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good yield over 5 simple steps. This strategy offers an alternative to current preparative 
methods of elaborate nitrogen-aryl cores, such as Friedel-Crafts reactions that tend to have 
lower selectivity and the Büchwald-Hartwig amination that does not always work with 
congested aromatic halides. 
2.8 Kinetic Diene Reaction Scope 
Diene 52a was submitted to the same reaction conditions with a variety of dienophiles 
and afforded the corresponding aromatic products (see Scheme 18). 
Scheme 18: Reaction Scope for Diene 52a 
 
 
The reactions worked in moderate to good yields, however two products were identified. 
Further investigation revealed that the expected products 65-69 were formed in addition to 
the corresponding regioisomeric product resulting from reaction of diene 51a with the 
respective acetylene. It became apparent that during the course of the Diels-Alder reaction a 
1,5-sigmatropic rearrangement was occurring. The starting ratio of the dienes 52a:51a was 
>10:1, but the product ratios were at best about 4:1. 
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Danishefsky never mentioned this rearrangement in his work likely because most of his 
1,3-cyclohexadione derived dienes were pseudo-symmetric and do not undergo the 
rearrangement. The idea had largely been overlooked, and only once briefly mentioned by 
Burnell, using a diene derived from dimedone outfitted with an –OTMS and –OMe group.28 
He mentions that with heat they see conversion from their desired diene to its isomer, but he 
does not perform any further studies to investigate his speculations. 
2.9 Unexpected 1,5-Sigmatropic Rearrangement 
Due to the limited precedent, we decided to further investigate this phenomenon. Core 
52a was enriched with deuterium to 80% and deprotonated to form diene 52d in a >10:1 
ratio of 52d:51d. When the kinetic diene 52d was heated, an increase in the amount of the 
thermodynamic diene 51d was not seen. However heating diene 52a does give some 
rearranged diene over 3d. This was nowhere near the magnitude observed in our Diels-Alder 
reactions, so we have speculated that the dienophile facilitates the rearrangement, but have 
not investigated this idea further. When diene 52d was heated in the presence of dimethyl 
acetylenedicarboxylate (DMAD), both products 53d and 65 were observed in about a 2:1 
ratio. This was consistent with what we observed under the same reaction conditions with 
diene 51a (see Scheme 19). 
Scheme 19: Deuteration Experiments 
  24 
 
Our observations support the possibility that addition of the acetylene forms a charge 
transfer complex between the acetylene and the diene that facilitates the 1,5-sigmatropic 
rearrangement.29 We anticipate that this 1,5-sigmatropic rearrangement occurs because the 
thermodynamic diene 51a that is fully conjugated with oxygen is more stable than the 
kinetic diene counterpart 52a that is cross-conjugated with oxygen. It should be noted that 
this same rearrangement was seen when dienes 52b and 52c were used for the Diels-Alder 
reaction, but no ratio improvements were observed. 
2.10 Method Application Strategy for Tetrapetalone A 
Our approach to tetrapetalone A began with the idea that the A ring probably could come 
from an aromatic intermediate like 70 (see Scheme 20).  
Scheme 20: Pettus’ Retrosynthesis of Tetrapetalone A 
 
We envisioned the seven- and five-membered rings could be elaborated using the 
appended functional handles on 71. We envisioned that these functional group tethers could 
be installed through our Diels-Alder and retro-Diels-Alder method by reaction of the 
N
TBSO Me
Me
CBzBn
52d
D
D
N
TBSO
CBzBn
D
CO2Me
CO2Me
+   65
53d
N
TBSO Me
Me
CBzBn
D
D
heat
1,5-Sigmatropic
Rearrangement
heat +
dienophile
1,5-Sigmatropic
Rearrangement
51d
N
OH
O
O
OR
OH
tetrapetalone A
1
N
OR2
O
R1O
O
R3
R4
N
OR2
O
R1O
R3
EWG
EWG
R4
O N
OR2
O
TBSO
R3
R4
O
OO
N
OR2
O
O
R3
R4
70 71 72 74
73
O
dimedone
OH
  25 
elaborate diene 72 with acetylene 73. Using a similar strategy that was employed in our 
model system, we envisioned forming our tetramic acid CVA 74 from the commercially 
available dimedone. 
2.11 Synthetic Application of our method to Tetrapetalone A 
To begin the synthesis, glycine methyl ester hydrochloride was condensed with 
dimedone to form 75 in excellent yield. This intermediate compound was then subjected to 
deprotonation using n-butyllithium followed by addition of 3-bromopropionylbromide to 
afford 76 in moderate yield (see Scheme 21). 
Scheme 21: Preparation of Synthetic Intermediate 78 
 
The acylated intermediate 76 was then subjected to a mild SmI2-cyclization using a 
method recently developed in our laboratory to afford the C-3 methylated tetramic acid 77 in 
good yield after addition of diazomethane.30 Deprotonation of 77 with KHMDS and addition 
of methyl iodide formed the C-5 methylated tetramic acid compound. This intermediate was 
again subjected to the same deprotonation conditions followed by addition of allyl bromide 
and afforded compound 78 in 13% yield over the 5 steps. With compound 78 in hand, we 
subjected it our recently developed deprotonation technique and obtained diene 79 in good 
to excellent yields (see Scheme 22). 
Scheme 22: Kinetic Deprotonation and Diels-Alder Reaction of 78 
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Unfortunately, the same 1,5-sigmatropic rearrangement that occurred in our model 
system occurred with our tetramic acid diene 79 and afforded a range of products (80-83) 
upon reaction with dienophile 73 (see Scheme 23).  
Scheme 23: Attempted Convergent Ring-Closure of 80-83 
 
However, we had envisioned that the mixture of isomers (80-83) could be submitted to 
basic conditions in a similar fashion to that we used successfully in our model system (see 
Scheme 16). Unfortunately, attempts to affect the same ring closure that we performed on 
our model system with this elaborate mixture of compounds proved unsuccessful. We turned 
to implement a simpler dienophile in hopes that with only two possible products, the 
products would be separable and isolated for use in further reactions (see Scheme 24). 
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We were pleased to find that submitting our elaborate diene 79 to our Diels-Alder 
reaction conditions with dimethylacetylenedicarboxylate (DMAD) furnished compound 86 
and its regioisomer in a good combined yield. Upon separation of phenol 86, we added a 
triisopropylsilyl protecting group to increase the molecular weight of the compound and 
attempted to further elaborate the methyl esters into the five-membered ring seen in 
tetrapetalone A.31 Unfortunately, despite many attempts, the product was not formed.  
2.12 Conclusion 
Using a simple and inexpensive starting material, we demonstrated that our strategy to 
form compounds containing nitrogen-aryl bonds works well to form meta-amino phenols 
decorated with a variety of differing functional groups on an aromatic core. We encountered 
an unprecedented 1,5-sigmatropic rearrangement that hindered the use of this method for 
application to tetrapetalone A. However, we were able to demonstrate the tolerance of this 
method and synthesize an elaborate diene which allowed construction of two of the ring 
skeletons in the tetrapetalone A target. 
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Chapter 3: Progress Toward a Vinylation Reagent 
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3.1 Another Piece of the Tetrapetalone A Puzzle 
While investigating different synthetic approaches to tetrapetalone A, our group probed 
the reactivity of the tetramic acid C-5 position.32 In our group's most recent synthetic 
approach, we aimed to install a vinyl group at the C-5 position so that it could used to install 
the ethyl group. However, when we encountered limitations among the current methods to 
install vinyl groups, we turned to develop a more general vinylation strategy. Our progress 
toward a "vinylation reagent" is reported and future directions will be discussed. 
3.2 Common Vinyl Group Surrogates 
One of the known methods to install a vinyl group is to add a nucleophile to one of the 
common electrophiles shown below and further manipulate the intermediate to obtain a 
vinylated product (see Figure 6). 
Figure 6: Common Electrophiles Used to Incorporate Vinyl Groups 
 
Nitroethylene (A) is one of these electrophiles, however it readily polymerizes and can 
only be stored as a 10% solution in dry benzene for about six months.33 Conjugate addition 
of nucleophiles to both the sulfide (B) and sulfone (C) afford products that can undergo 
elimination in a similar fashion to afford alkenes.34 The vinyl sulfoxide (D) is also a good 
electrophile and the conjugate addition product can undergo elimination in a similar fashion 
to the selenoxide elimination (E).35 The selenoxide elimination is well known and used 
fairly often in synthesis.36 However selenium is toxic and there is a high motivation to 
decrease the use of toxic materials as organic synthesis makes steps towards green 
chemistry.37  
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3.3 Pettus’ Approach to Tetrapetalone A 
In a different strategy to tetrapetalone A, the Pettus group synthesized the tricycle 87 and 
made many attempts to install a vinyl group to obtain intermediate 88 to be further 
elaborated into the ethyl group at the highlighted C-5 carbon (see Scheme 25).38  
Scheme 25: Pettus Group Attempts to Install the Ethyl Group 
 
However, most of the traditional vinyl group surrogates failed to afford synthetically 
useful intermediates (see Figure 6). With our unproductive attempts using common methods, 
work by Zard provided a prospect for this approach for the natural product. 
3.4 β-Nitro Xanthates to Form Alkenes 
In 2003, the Zard group published their work using β-nitro xanthates as olefin 
precursors.39 Zard showed that nitroolefin Henry adducts could undergo conjugate addition 
of potassium ethyl xanthogenate in acetic acid and chloroform (see Scheme 26). 
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Submission of the conjugate addition products to heat with the radical initiator dilauroyl 
peroxide afforded the desired alkene products. Zard shows that his bond disconnection is 
useful to afford styrenes, internal alkenes and a few terminal alkenes. To test the viability of 
this strategy, our group installed a vinyl nitro substituent to the tetramic acid C-5 carbon of 
compound 87 (see Scheme 27).38 
Scheme 27: Installation of the Tetrapetalone A Ethyl Group 
 
Long-range deprotonation of 87 and addition of the triene to the sulfone (see Figure 6, 
C) furnished the vinyl nitro product 89 in 80% yield. With this adduct in hand, our group 
tested Zard’s chemistry and found that the addition of potassium ethyl xanthogenate 
followed by the radical reaction with AIBN and Bu3SnH furnished the vinylated product. 
Hydrogenation of the vinylated material using Wilkinson’s catalyst afforded the desired 
compound 90 in good yield. 
With the success of this mild reaction, we wanted to broaden the possible ways to 
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addition products could then undergo radical reaction using dilauroyl peroxide or with the 
standard tin conditions to afford the corresponding vinylated products (see Scheme 28). 
Scheme 28: Vinylation Reagent Goals 
 
Our group had already demonstrated that we could make a bond disconnection distinct 
from Zard’s in our application to tetrapetalone A (see Scheme 27), but our aim was to 
shorten the synthetic sequence and make it more general. We intended to do this by 
synthesizing a “vinylation reagent” that would allow a different synthetic bond 
disconnection (highlighted in red) to be made and afford vinylated products in only 2 steps 
using mild reaction conditions. 
3.6 Sulfone Synthesis 
We began the synthesis of our vinylation reagent by starting from the known 
phenylvinylnitrosulfone 91 (see Scheme 29). 
Scheme 29: Sulfone Synthesis 
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addition with potassium ethyl xanthogenate to invoke the elimination of phenyl sulfinic acid 
and obtain the first generation of our vinylation reagent. 
3.7 Vinylation Reagent Synthesis 
Potassium ethyl xanthogenate was added to the synthesized sulfone 91 to give a mixture 
of the cis- and trans-xanthate reagent 92 (see Scheme 30).  
Scheme 30: Synthesis of the Xanthate Vinylation Reagent 
 
Upon purification of the reaction mixture, we found that our desired reagent could be 
synthesized, but in only 10-30% yield and as a mixture of isomers. The alkene isomer 
products were inconsequential, but the yield was not acceptable for general use of this 
reagent. Characterization of the side-products revealed that the thioacetal 93 and the product 
94 resulting from both the conjugate addition and nitro group substitution were also formed 
under the reaction conditions. After many attempts at purifying the side-products from the 
desired vinylation reagent isomers, the thioacetal product 93 could not be removed 
effectively. The thioacetal product was sandwiched between the trans- and cis-isomers of 
our desired reagent 92 which did not lend to simple purification. Despite efforts to use the 
thioacetal product 93 as a precursor to the desired product, all attempts were unsuccessful.41 
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93 and 94 by changing the order of addition, the equivalents of the reagents and the reaction 
time (see Scheme 31). 
Scheme 31: Modified Reaction Conditions 
 
However, the low yields were persistent. To reason through these results, we turned to 
look at the pKa values of the conjugate acids in our addition and elimination reactions. 
3.8 pKa Analysis 
The pKa of the conjugate acid of the phenyl sulfinate leaving group is 2.5. The pKa of 
the conjugate acid of our xanthate nucleophile is lower than this and has been reported to be 
between 1.7 and 2.0 (see Figure 7).42 
Figure 7: pKa values of Relevant Acids 
 
We attributed the low yield of our vinylation reagent to the unfavored reaction 
conditions that result from the higher pKa value of the conjugate acid of our leaving group 
compared to that of our xanthic acid nucleophile. With this notion in mind, we turned to 
determine another nucleophile or leaving group that would favor our desired reaction.  
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3.9 Synthetic Route Variation 
We attempted to decrease the pKa value of the sulfone leaving group by using bis-
trifluoromethylthiophenol in our synthesis of the beta-nitrovinylsulfone. The synthesis 
began with the addition of bis-trifluoromethylthiophenol to the previously synthesized 
acetate which afforded the β-nitro substitution product 95 (see Scheme 32). 
Scheme 32: Attempt to Decrease the pKa of Sulfone Leaving Group 
 
Although the overall substitution reaction worked quite well, the chlorination and 
elimination reaction failed to afford the desired unsaturated product and returned starting 
material. We thought that we could continue to use the original sulfone 91 if the xanthate 
nucleophile had a higher pKa value compared to the conjugate acid of the sulfinate leaving 
group. We turned to use the dimethyldithiocarbamate salt as our nucleophile because the 
conjugate acid has a pKa value of 5.4 compared to the sulfinate leaving group at 2.5 (see 
Scheme 33). 
Scheme 33: Synthesis of the Vinylation Reagent with Dimethyldithiocarbamate 
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xanthogenate derivative (see Scheme 30). The main advantages were that the corresponding 
thioacetal and nitro-substitution product were more polar and could therefore be separated 
quite easily if they formed. However, the two undesired by-products formed when the 
equivalents of the xanthate salt were high or the reaction was allowed to run longer than two 
hours. Acetic acid was not used because it did not have consequences on the reaction as it 
did in the reaction with the ethyl xanthogenate. With two different vinylation reagents in 
hand, the conjugate addition reactions were attempted with different nucleophiles. 
3.10 Conjugate Addition to the Vinylation Reagent 
The effectiveness of the reagent was first tested with a model system we had used to 
probe the reactivity of the tetramic acid C-5 carbon.43 Upon deprotonation of the tetramic 
acid and addition of the electrophile, the reaction proceeded to afford compound 98 (see 
Scheme 34). 
Scheme 34: Conjugate Addition of Tetramic Acid to the Vinylation Reagent 
 
Although the reaction proceeded to give our desired product 98, the yield remained quite 
low at only 48%. Despite the marginal yield, we proceeded to test the radical reaction on our 
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3.11 Radical Reaction to Install a Vinyl Group 
The radical reaction of the conjugate addition product 98 proceeds much smoother and 
afforded the vinylated product 99 (see Scheme 35). 
Scheme 35: Radical Reaction to Affect the Vinylation 
 
The radical reaction was attempted with dilauroyl peroxide and the conventional 
AIBN/Bu3SnH and AIBN/Ph3SnH. All of the reactions furnished the vinylated product in 
similar high yields, so we chose to proceed with the most benign dilauroyl peroxide reagent. 
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Table 2: Vinylation Reagent Reaction Scope 
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number of synthetic steps required for our synthetic approach to tetrapetalone A (see 
Scheme 36). 
Scheme 36: Demonstration of Vinylation Reagent Feasibility for Tetrapetalone A 
 
Although we were able to synthesize a "vinylation reagent," the synthesis was tedious so 
we began investigations into another reasonable route to prepare the vinylation reagent. 
3.13 Alkene Nitration Methods 
Upon searching the literature, many methods for nitration of alkenes were found. These 
methods usually furnished the product by either a cationic mechanism44 or a radical 
mechanism.45 The nitration processes that occurred by a cationic mechanism were most 
promising since we hoped our reagent would react under radical conditions (see Scheme 
37).44 
Scheme 37: Proposed Cationic Mechanism of Nitroolefin Formation 
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3.14 Vinyl Xanthate Synthesis and Nitration Attempts 
In order to use the reported nitration methods, we began with the synthesis of the known 
disulfides 105 and 107 by oxidation with iodine.46 Subsequent addition of vinyl grignard to 
each intermediate afforded the corresponding vinyl xanthates 106 and 108 in excellent 
yields over the 2 steps (see Scheme 38).47 
Scheme 38: Synthesis of vinyl xanthates 106 and 108 
 
However, attempts to add the nitro group to the vinyl functional group using both the 
previously reported cationic and radical protocols were unsuccessful. 
3.15 Conclusions and Future Work 
Despite having some successes that proved our concept of a vinylation reagent, the 
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include any compounds that could be removed through a gentle radical process and may 
include compounds containing stannanes or Barton esters. 
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Experimental Section  
General Techniques 
In reactions, where water was not present as solvent, reagent, or as a by-product, 
vessels were flame-dried under a slow nitrogen flow. A slight positive pressure of dry 
nitrogen was maintained via rubber septa seal during the course of the reaction. The 
nitrogen stream originated from a regulated high pressure 55 L N2(l) tank and was further 
dried by passage through a tube filled with Drierite®. Reagents were purified according 
to the procedures describe in the Perrin & Perrin laboratory manual. 
Reactions were monitored by analytical thin-layer chromatography on EM-Science 
hard layer silica gel-60F-250 plates cut into 1 x 2.5 cm pieces. Visualization was effected 
by ultraviolet light (254 nm), followed by staining [Seebach or permanganate] the plate 
and drying with a heat gun.  The Seebach stain was made with 2.5 g of phosphomolybdic 
acid, 1.0 g of cerium sulfate, 6 mL H2SO4, and 94 mL of H2O. The potassium 
permanganate stain was made with 198 mL H2O, 1.5 g KMnO4, 10.0 g of K2CO3, and 2 
mL of 10% NaOH. 
All reactions were stirred with Teflon®-coated magnetic stir bars by Thomas® 
Magne- Matic magnetic stirrers. Removal of solvents was typically accomplished using a 
Buchi® rotary evaporator (model #R-114) connected to a Fisher KNF®-vacuum pump 
(model #UN820-3). The condenser was cooled to -2 °C by a Fisher® chiller circulator 
bath (model #1013S). If the product was non-volatile, trace solvents were removed using a 
Labconco® freeze dryer system at a pressure of approximately 0.01 mmHg. Ethyl 
acetate (anhydrous) and hexanes were utilized directly from the bottle. Deuterated 
chloroform was filtered through basic alumina prior to use. Solvents were distilled 
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before use, under a slight positive pressure of nitrogen. Diethyl ether, tetrahydrofuran, 
benzene, and toluene were distilled from sodium and benzophenone. Dichloromethane 
was distilled from CaH2. Chloroform was filtered through alumina before being 
fractionally distilled. For distillation, a specific low pressure (760 – 1 mm Hg) was 
obtained and monitored with a Buchi®-vacuum controller (model #B-721) in combination 
with a Welch® direct drive pump (model #8915A). Lower pressures were achieved using 
a vacuum manifold connected to an oil- diffusion pump and backed by a Welch® direct 
drive vacuum pump, (model #8910A). 
1H-NMR spectra were recorded at 400 MHz, 500 MHz or AS600 600 MHz on a 
Varian® Unity Inova spectrometer. Select spectra were recorded at 800 MHz on a Bruker 
Avance III Ultrashield Plus spectrometer. Chemical shifts are reported in ppm after 
referencing the solvent resonance of CDCl3 (7.26 ppm) or benzene (7.16 ppm). 13C NMR 
spectra were recorded at 600 MHz with a solvent resonance of CDCl3 (77.16 ppm) or 
benzene (128.06 ppm). NMR spectra were evaluated using iNMR, MaestraNova or VNMR-
J. 
Infrared spectra were recorded on a Shimadzu® FTIR-8300 Fourier transform 
infrared spectrometer neat. Infrared frequencies are reported in reciprocal centimeters 
(cm-1). UV-Vis spectra were recorded using a Beckman DU- 640 UV-Vis 
spectrophotometer. 
Accurate mass measurement data (i.e. HRMS) were obtained on an electrospray 
ionization/time-of-flight mass spectrometer. 
Diels-Alder reactions were set-up in one of two ways. ACE sealed tubes were used 
with a nitrogen blanket over the reaction vessel and sealed using a teflon threaded cap with 
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an O-ring. Alternatively, reaction vials lined with teflon tape on the threads and sealed with 
a cap lined with a teflon liner insert were used for smaller volumes. The reaction vessel 
was chosen so that the reaction volume was a minimum of half the total vessel volume. 
Commercial acetylenes were used out of the bottle if they were purchased recently. 
If they were used after being stored for a prolonged period of time, they were purified by 
Kügelröhr distillation, then used. Prepared acetylenes were purified or used crude as 
noted within their methods of preparation. 
Experimental Procedures 
Preparation of CVAs (modification and expansion of known methods)48 
Procedure 1: Compound 50a precursor 
 
Dimedone (5.0 g, 35.7 mmol, 1.00 equiv.), BnNH2 (3.9 mL, 35.7 mmol, 1.0 equiv.), p-
TsOHH2O (679 mg, 3.57 mmol, 10%), Na2SO4 (10.14 g, 71.4 mmol, 2 equiv.) and benzene 
(30 mL, 1.2 M dimedone) were added to a sealed tube. The mixture was heated at 85 °C 
overnight. The solution was then concentrated and diluted with CH2Cl2, washed 3x with 
sat’d NaHCO3 and 1x with brine. The organic layer was dried over Na2SO4, filtered and 
concentrated in vacuo to yield 50a precursor (quant.). The solid product was recrystallized 
in benzene to afford known compound 50a precursor as bright yellow crystals (86% yield). 
This procedure also works by refluxing the reaction instead of using the sealed tube set-up. 
1H NMR (400 MHz, CDCl3): δ 7.38-7.25 (m, 5H), 5.24 (br s, 1H), 4.83 (br s, 1H), 4.27 
(d, J = 5.20 Hz, 2H), 2.32 (s, 2H) 2.21 (s, 2H), 1.08 (s, 6H).  
NH
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Procedure 2: Compound 50a 
 
Ene-amine 50a precursor (796 mg, 3.47 mmol, 1.0 equiv.) was azeotroped 3x in 
toluene, then diluted in THF (22 mL, 0.16 M 50a precursor) and put over 4Å MS. This 
solution was cannulated into a 100 mL flame-dried RBF. The solution was cooled to -78 °C 
and n-BuLi (1.08 mL, 3.17 M, 3.42 mmol, 1.0 equiv.) was added slowly to form a deep-red 
solution. This solution was stirred for 2h at -78 °C, then benzyl chloroformate (694 µL, 1.4 
equiv.) was added neat. The reaction vessel was allowed to warm to rt overnight. The 
reaction was quenched with sat’d NaHCO3 and extracted using EtOAc. The organic layer 
was washed with brine, dried using Na2SO4, filtered and concentrated in vacuo. The crude 
yellow oil was purified using column chromatography (SiO2, eluent: hexanes to 20% ethyl 
acetate, 80% hexanes) to yield 50a (1.082 g, 86%) as a light yellow oil. Recrystallization 
from benzene gives a very light yellow or white crystalline solid. 
1H NMR (600 MHz, CDCl3): δ 7.33-7.13 (m, 10H), 5.75 (s, 1H), 5.20 (s, 2H), 4.87 (s, 
2H), 2.58 (s, 2H), 2.17 (s, 2H), 0.94 (s, 6H).; 13C NMR (151 MHz, CDCl3): δ 199.65, 
160.49, 154.18, 136.78, 135.38, 128.88, 128.74, 128.65, 128.50, 127.64, 126.69, 116.86, 
68.68, 52.89, 50.66, 44.25, 34.11, 28.08.; HRMS (ESI/TOF) m/z calculated for 
C23H25NO3Na: [M + Na]+ 386.1722; found 386.1732.; IR (neat) cm-1: 2956, 1721, 1712, 
1660, 1652, 1455, 1393, 1367, 1359, 1300, 1209, 1126, 1025, 873, 734, 698.; Rf=0.20 (20% 
ethyl acetate, 80% hexanes). 
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Procedure 3: Compound 50b precursor 
 
1,3-Cyclohexanedione (200 mg, 1.78 mmol, 1.00 equiv.), BnNH2 (195 µL, 1.78 mmol, 
1.0 equiv.), p-TsOHH2O (34 mg, 0.178 mmol, 10%), Na2SO4 (506 mg, 3.56 mmol, 2 
equiv.) and benzene (1.5 mL, 1.2 M dione) were added to a sealed tube. The mixture was 
heated at 85 °C overnight. The solution was then concentrated and diluted with EtOAc, 
washed 3x with sat’d NaHCO3 and 1x with brine. The organic layer was dried over Na2SO4, 
filtered and concentrated in vacuo to yield known compound 50b precursor (165 mg, 46%) 
as a brown oil which was used crude. This procedure also works by refluxing the reaction as 
opposed to using the sealed tube set-up. 
1H NMR (500 MHz, CDCl3): δ 7.38-7.26 (m, 5H), 5.21 (s, 1H), 4.65 (br s, 1H), 4.23 (d, 
J = 5.25 Hz, 2H), 2.34-2.32 (m, 4H), 1.99 (t, J = 6.3, 2H). 
Procedure 4: Compound 50b 
 
Ene-amine 50b precursor (160 mg, .795 mmol, 1.0 equiv.) was azeotroped 3x in 
toluene, then diluted in THF (10 mL, 0.16 M 50b precursor) and put over 4Å MS. This 
solution was cannulated into a 50 mL flame-dried RBF. The solution was cooled to -78 °C 
and n-BuLi (0.374 mL, 2.55 M, .954 mmol, 1.2 equiv.) was added slowly to form a deep-red 
solution. This solution was stirred for 1h at -78 °C, then benzyl chloroformate (694 µL, 1.4 
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equiv.) was added neat. The reaction vessel was allowed to warm to rt overnight. The 
reaction was quenched with sat’d NaHCO3 and extracted using EtOAc. The organic layer 
was washed with brine, dried using Na2SO4, filtered and concentrated in vacuo. The crude 
yellow oil was purified using column chromatography (SiO2, eluent: hexanes to 25% ethyl 
acetate, 75% hexanes) to yield 50b (195 mg, 73%) as a brown oil. 
1H NMR (600 MHz, solvent): δ 7.32-7.12 (m, 10H), 5.74 (s, 1H), 5.19 (s, 2H), 4.87 (s, 
2H), 2.74 (t, J = 5.4 Hz, 2H), 2.34 (t, J = 6.6 Hz, 2H), 1.94 (q, J = 6.00 Hz, 2H).; 13C NMR 
(151 MHz, CDCl3): δ 199.60, 162.82, 154.08, 136.78, 135.43, 128.93, 128.75, 128.61, 
128.36, 127.60, 126.42, 117.26, 68.64, 52.94, 37.00, 30.35, 23.16.; HRMS (ESI/TOF) m/z 
calculated for C21H21NO3: [M + Na]+ 358.1419; found 358.1414.; IR (neat) cm-1: 3064, 
3032, 2952, 2925, 2359, 2340, 1715, 1667, 1593, 1496, 1455, 1393, 1231, 1213, 1185, 
1125, 1011, 911, 732.; Rf=0.13 (20% ethyl acetate, 80% hexanes). 
Procedure 5: Compound 50c precursor 
 
5-phenyl-1,3-Cyclohexanedione (500 mg, 2.66 mmol, 1.00 equiv.), BnNH2 (290 µL, 
2.66 mmol, 1.0 equiv.), p-TsOHH2O (51 mg, 0.27 mmol, 10%), Na2SO4 (756 mg, 5.32 
mmol, 2 equiv.) and benzene (2.2 mL, 1.2 M dione) were added to a sealed tube. The 
mixture was heated at 85 °C overnight. The solution was then concentrated and diluted with 
EtOAc, washed 3x with sat’d NaHCO3 and 1x with brine. The organic layer was dried over 
Na2SO4, filtered and concentrated in vacuo to yield known compound 50c precursor (590 
NH
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mg, 80%) as a bright yellow powder that was used crude. This procedure also works by 
refluxing the reaction as opposed to using the sealed tube set-up. 
1H NMR (400 MHz, CDCl3): δ 7.37-7.22 (m, 10H), 5.28 (s, 1H), 4.66 (br s, 1H), 4.26 
(d, J = 4.80 Hz, 2H), 3.39 (m, 1H), 2.75-2.42 (m, 4H). 
Procedure 6: Compound 50c 
 
Ene-amine 50c precursor (550 mg, 1.98 mmol, 1.0 equiv.) was azeotroped 3x in Ph-
Me, then diluted in THF (20 mL, 0.16 M, 50c precursor) and put over 4Å MS. This 
solution was cannulated into a 50 mL flame-dried RBF and cooled to -78 °C. n-BuLi (0.8 
mL, 2.97 M, 2.38 mmol, 1.2 equiv.) was added slowly to form a deep-red solution. This 
solution was stirred for 2h at -78 °C, then benzyl chloroformate (396 µL, 1.4 equiv.) was 
added neat. The reaction vessel was allowed to warm to rt overnight. The reaction was then 
quenched with sat’d NaHCO3 and extracted using EtOAc. The organic layer was washed 
with brine, dried using Na2SO4, filtered and concentrated in vacuo. The crude yellow oil was 
purified using column chromatography (SiO2, eluent: hexanes to 20% ethyl acetate, 80% 
hexanes) to yield 50c (594 mg, 73%) as an off-white powder. 
1H NMR (600 MHz, CDCl3): δ 7.27-7.07 (m, 15H), 5.75 (s, 1H), 5.11 (q, J = 12 Hz, J = 
7.8 Hz, 2H), 4.95 (d, J = 16.8 Hz, 1H), 4.73 (d, J = 16.8 Hz, 1H), 3.18-3.14 (m, 1H), 2.96-
2.86 (m, 2H), 2.58-2.47 (m, 2H).; 13C NMR (151 MHz, CDCl3): δ 198.77, 161.68, 154.02, 
142.83, 136.62, 135.21, 128.97, 128.88, 128.75, 128.66, 128.49, 127.66, 127.19, 126.87, 
126.42, 116.72, 68.81, 53.06, 43.87, 41.33, 38.26.; HRMS (ESI/TOF) m/z calculated for 
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C27H25NO3: [M + Na]+ 434.1732; found 434.1711.; IR (neat) cm-1: 3063, 3030, 2952, 2894, 
1715, 1596, 1496, 1454, 1393, 1356, 1204, 1131, 1040, 1029, 1013, 910, 759, 734.; Rf=0.23 
(20% ethyl acetate, 80% hexanes). 
Preparation of Thermodynamic Dienes Using Method C Equilibration Conditions 
Procedure 7: Compound 51a 
 
CVA 50a (1.5 g, 4.13 mmol, 1.3 equiv.) was azeotroped 3x in toluene and diluted in 
THF (180 mL, 0.023 M 50a), then put over 4Å MS. This solution was cannulated into a 250 
mL RBF and cooled to 0 °C. Upon addition of KHMDS (3.5 mL, 3.18 mmol, 0.917 M in 
THF, 1.0 equiv.) a darker yellow solution formed and was kept stirring at 0 °C for 5h. At 
this time, tert-butyldimethylsilyl chloride (528 mg, 3.5 mmol, 1.1 equiv.) was added in three 
portions using THF (20 mL). This solution was allowed to warm to rt over 2h. This solution 
was concentrated and filtered over a frit with a 1” silica gel pad treated with 3% Et3N, 97% 
hexanes using 5% ethyl acetate, 3% Et3N, 92% hexanes as the eluent. This afforded 51a 
(1.111 g, 73%) as a light yellow oil. This was then stored in a freezer in benzene and stable 
for weeks. 
1H NMR (400 MHz, CDCl3): δ 7.27-7.18 (m, 10H), 5.12 (s, 2H), 4.84 (br s, 1H), 4.82 
(br s, 1H), 4.56 (s, 2H), 1.99 (s, 2H), 0.89 (s, 6H), 0.84 (s, 9H), 0.02 (s, 6H).; 13C NMR (151 
MHz, CDCl3): δ 153.95, 138.21, 135.94, 135.28, 128.43, 128.40, 128.34, 127.77, 127.50, 
127.28, 125.07, 103.25, 69.79, 67.11, 53.20, 43.46, 33.18, 28.08, 25.70, 18.07, -4.34.; No 
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HRMS, IR or Rf data taken due to the diene sensitivity. The acid sensitive compound was 
used crude. 
Procedure 8: Compound 51b 
 
CVA 50b (108 mg, 0.322 mmol, 1.2 equiv.) was azeotroped 3x in toluene and diluted in 
THF (13 mL, 0.025 M 50b), then put over 4Å MS. This solution was cannulated into a 50 
mL RBF and cooled to 0 °C.  KHMDS (0.292 mL, 0.268 mmol, 0.917 M in THF, 1.0 
equiv.) was added and stirred at 0 °C for 5.5h. At this time, tert-butyldimethylsilyl chloride 
(56 mg, 0.375 mmol, 1.4 equiv.) was added in three portions using THF (3 mL). This 
solution was allowed to warm to rt over 2h. This solution was concentrated and filtered 
over a frit with a 1” silica gel pad treated with 3% Et3N, 97% hexanes using 5% ethyl 
acetate, 3% Et3N, 92% hexanes as the eluent.  This afforded 51b (49 mg, 36%) as a yellow 
oil. This was then used immediately, but should be stable to storage. 
1H NMR (600 MHz, CDCl3): δ 7.33-7.17 (m, 10H), 5.13 (s, 2H), 5.10 (br s, 1H), 4.86 
(br s, 1H), 4.56 (s, 2H), 2.23-2.19 (m, 2H), 2.11-2.08 (m, 2H), 0.84 (s, 9H), 0.03 (s, 6H).; 
13C NMR (151 MHz, CDCl3): δ 155.05, 138.39, 136.98, 128.71, 128.47, 128.45, 128.42, 
128.11, 127.84, 127.61, 127.24, 113.25, 104.26, 67.20, 53.27, 28.31, 25.71, 22.89, 18.15, -
4.43.; No HRMS, IR or Rf data taken due to the diene sensitivity. The acid sensitive 
compound was used crude. 
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Procedure 9: Compound 51c 
 
CVA 50c (100 mg, 0.243 mmol, 1.2 equiv.) was azeotroped 3x in toluene and diluted in 
THF (10 mL), then put over 4Å MS. This solution was cannulated into a 50 mL RBF and 
cooled to 0 °C.  KHMDS (0.221 mL, 0.203 mmol, 0.917 M in THF, 1.0 equiv.) was added 
and kept stirring at 0 °C for 5.5h. At this time, tert-butyldimethylsilyl chloride (43 mg, 
0.284 mmol, 1.4 equiv.) was added using THF (3 mL). This solution was allowed to warm 
to rt over 2h. It was purified by filtration over a frit with a 1” silica gel pad treated with 3% 
Et3N, 97% hexanes using 5% ethyl acetate, 3% Et3N, 92% hexanes as the eluent. This 
afforded 51c (23 mg, 22%) as a light yellow oil. This was then used immediately, although 
it probably would be stable to storage by freezing in benzene. 
1H NMR (600 MHz, CDCl3): δ 7.38-7.12 (m, 15H), 5.22-5.17 (m, 3H), 4.99 (br s, 1H), 
4.67 (q, J = 14.7 Hz, 12.6 Hz, 2H), 3.68 (m, 1H), 2.55-2.51 (m, 1H), 2.29-2.24 (m, 1H), 
0.84 (s, 9H), 0.00 (d, J = 34.8 Hz, 6H).; 13C NMR (151 MHz, CDCl3): δ 153.68, 144.42, 
138.16, 136.84, 128.73, 128.56, 128.54, 128.32, 127.97, 127.84, 127.67, 127.37, 126.57, 
104.13, 69.87, 67.45, 53.10, 40.51, 37.59, 25.72, 18.09, -4.37 + -4.57 (same carbon).; No 
HRMS, IR or Rf data taken due to the diene sensitivity. The acid sensitive compound was 
used crude. 
Preparation of Kinetic Dienes Using Method A and B 
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Procedure 10: Compound 52a 
 
Method A: Recently sublimed KOt-Bu (278 mg, 2.48 mmol, 1.5 equiv.) was added to a 
flame-dried 100 mL RBF and lightly flame-dried. The solid was diluted in THF (5 mL) and 
cooled to -78 °C.  n-BuLi (0.84 mL, 2.48 mmol, 2.97 M, 1.5 equiv.) was then added to the 
mixture and stirred for 20 minutes. CVA 50a (600 mg, 1.65 mmol, 1.0 equiv.) was 
azeotroped 3x in toluene and diluted in THF (35 mL, 0.023 M 50a), then put over 4Å MS. 
This solution was cannulated slowly into the reaction mixture at -78 °C and stirred for 10 - 
15 minutes forming a yellow-brown solution. tert-Butyldimethylsilyl chloride (497 mg, 3.3 
mmol, 2 equiv.) was then added via cannula using THF (3 mL). This solution was allowed 
to warm to rt slowly over 7h.  The reaction vessel was concentrated in vacuo. The product 
was then filtered over a frit with a 1” silica pad treated with 3% Et3N, 97% hexanes using 
5% ethyl acetate, 3% Et3N, 92% hexanes as the eluent. This afforded 52a (487 mg, 62%) as 
a dark yellow oil in a >10:1 ratio of 52a:51a. This was then used immediately. Storage in 
the freezer in benzene led to erosion of the diene ratio 52a:51a. 
Method B: KHMDS (1.2 equiv., 1.0 M in THF) was cooled to -78 °C in a RBF. CVA 
50a (1.0 equiv.) was azeotroped 3x in toluene, then diluted in THF to make an 
approximately 0.015 M solution and put over 4Å MS. This solution was cannulated slowly 
to the vessel at -78 °C and stirred for 20 min.  tert-Butyldimethylsilyl chloride (31.4 mg, 
0.209 mmol, 1.4 equiv.) in THF (2 mL) was cannulated to the reaction mixture at -78 °C. 
This solution was allowed to warm slowly to rt over 7h. The reaction vessel was 
N
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concentrated in vacuo and filtered over a frit with a 1” silica pad treated with 3% Et3N, 97% 
hexanes using 5% ethyl acetate, 3% Et3N, 92% hexanes as the eluent. This afforded 52a as a 
very light yellow oil in a 7:1 or 5:1 ratio of 52a:51a. The diene mixture was then used crude. 
This diene was stable to storage in benzene for a few days, but the diene ratio erodes slowly 
when stored. This compound is acid sensitive. 
1H NMR (500 MHz, CDCl3) δ 7.32-7.00 (m, 10H), 5.61 (d, J =1.5 Hz, 1H), 5.12 (s, 2H), 
4.66 (d, J = 1.5 Hz, 1H), 4.60 (s, 2H), 2.22 (s, 2H), 0.98 (s, 6H), 0.94 (s, 9H), 0.06 (s, 6H).; 
No 13C data, HRMS, or IR data taken due to the diene ratio and acid sensitivity. The 
compound was used crude.; Rf=0.80 (Et3N SiO2 TLC plate, 5% ethyl acetate, 95% hexanes), 
acid sensitive. 
Procedure 11: Compound 52b 
 
KHMDS (0.18 mL, 0.179 mmol, 0.98 M in THF, 1.2 equiv.) was cooled to -78 °C in a 
50 mL RBF.  CVA 50b (50 mg, 0.149 mmol, 1.0 equiv.) was azeotroped 3x in toluene, then 
diluted in THF (8 mL) and put over 4Å MS. This solution was cannulated slowly to the 
vessel at -78 °C and stirred for 20 min.  tert-Butyldimethylsilyl chloride (31.4 mg, 0.209 
mmol, 1.4 equiv.) in THF (2 mL) was cannulated to the reaction mixture at -78 °C. This 
solution was allowed to warm slowly to rt over 7h. The reaction vessel was concentrated in 
vacuo and filtered over a frit with a 1” silica pad treated with 3% Et3N, 97% hexanes using 
5% ethyl acetate, 3% Et3N, 92% hexanes as the eluent. This afforded 52b (487 mg, 61%) as 
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a very light yellow oil in a 4:1 ratio of 52b:51b. This was then used immediately. Storage 
may result in isomerization to a degraded diene ratio, but was not tested. 
1H NMR (400 MHz, CDCl3) δ 7.33-7.23 (m, 10H), 5.47 (s, 1H), 5.18 (s, 2H), 4.76 (t, J = 
2.8 Hz, 1.6 Hz, 1H), 4.72 (s, 2H), 2.25-2.10 (m, 4H), 0.87 (s, 9H), 0.06 (s, 6H).; No 13C 
data, HRMS, IR or Rf data were obtained due to the diene ratio and acid sensitivity. The 
diene was used crude. 
Procedure 12: Compound 52c 
 
KHMDS (0.19 mL, 0.175 mmol, 0.98 M in THF, 1.2 equiv.) was cooled to -78 °C in a 
50 mL RBF. CVA 50c (60 mg, 0.146 mmol, 1.0 equiv.) was azeotroped 3x in toluene, then 
diluted in THF (8 mL) and put over 4Å MS. This solution was cannulated slowly to the 
vessel at -78 °C and stirred for 10 min. tert-Butyldimethylsilyl chloride (31 mg, 0.204 
mmol, 1.4 equiv.) in THF (2 mL) was then cannulated to the reaction mixture at -78 °C. 
This solution was allowed to warm slowly to rt over 7h. The reaction vessel was 
concentrated in vacuo and diluted in ether. This solution was then filtered over dry celite, 
then concentrated. This afforded 52c (50 mg, 64%) as a light yellow oil in a >10:1 ratio of 
52c:51c. The diene was then used immediately. Storage may result in isomerization to a 
degraded diene ratio, but was not tested. 
1H NMR (500 MHz, CDCl3) δ 7.38-7.11 (m, 15H), 5.49 (s, 1H), 5.11-5.00 (m, 2H), 
4.80-4.79 (m, 1H), 4.69-4.52 (m, 2H), 3.59-3.52 (m, 1H), 2.57-2.28 (m, 2H), 0.85 (s, 9H), 
0.04 (s, 6H).; No 13C data, HRMS, or IR data taken due to the diene ratio. The acid sensitive 
N
TBSO
CBz
52c
Bn
Ph
H
  55 
compound was used crude.; Rf=0.76 (Et3N SiO2 TLC plate, 5% ethyl acetate, 95% hexanes), 
acid sensitive. 
Thermodynamic Diene Aromatic Diels-Alder & retro-Diels-Alder Products 
General Procedure: Diene 51a was prepared and stored in benzene frozen until needed 
for use. For the following reactions, 51a (0.14 M in benzene) and the corresponding 
acetylene (≥2 equiv., neat) were added to a sealed tube using the outlined general conditions 
for sealed tube reactions. Each vial was then heated at 150 °C for 12-16h (although 
reactions were probably complete after 5-8h). The contents were diluted in EtOAc, 
transferred to a RBF and concentrated in vacuo. The crude contents were then purified by 
gradient column chromatography (SiO2, eluent: varying solvent conditions) to afford 
products 53-61. 
Procedure 13: Compound 53 
 
Diene 51a (238 mg, 0.5 mmol, 1.0 equiv., in benzene) and 
dimethylacetylenedicarboxylate (123 µL, 1.0 mmol, 2.0 equiv.) were heated at 150 °C in a 
sealed vial overnight. Purification by gradient column chromatography (SiO2, eluent: 
hexanes to 12% ethyl acetate, 88% hexanes) yielded 53 (240 mg, 85%) as a light yellow 
viscous oil. 
1H NMR (600 MHz, CDCl3): δ 7.49 (br s, 1H), 7.32-7.17 (m, 10H), 6.71 (br s, 1H), 5.19 
(s, 2H), 4.87 (s, 2H), 3.88 (s, 3H), 3.84 (s, 3H), 0.89 (s, 9H), 0.01 (s, 6H).; 13C NMR (151 
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MHz, CDCl3): δ 167.56, 165.20, 155.12, 152.92, 143.22, 137.24, 136.08, 129.16, 128.72, 
128.54, 128.37, 128.14, 127.99, 127.62, 125.97, 121.82, 120.69, 67.84, 54.00, 52.57, 52.44, 
25.40, 17.94, -4.64.; HRMS (ESI/TOF) m/z calculated for C31H37NO7SiNa: [M + Na]+ 
586.2237; found 586.2216.; IR (neat) cm-1: 2951, 2929, 1738, 1733, 1716, 1429, 1322, 
1238, 1100, 1036, 834, 786.; Rf=0.22 (10% ethyl acetate, 90% hexanes). 
Procedure 14: Compound 54 
 
Diene 51a (238 mg, 0.5 mmol, 1.0 equiv., in benzene) and bis(2,2,2-trifluoroethyl) 
acetylenedicarboxylate (90%, 1.11 mL, 1.0 mmol, 2.0 equiv.) were heated at 150 °C in a 
sealed vial overnight. Purification by gradient column chromatography (SiO2, eluent: 
hexanes to 20% ethyl acetate, 80% hexanes) yielded 54 (221 mg, 63%) as a light yellow 
viscous oil. 
1H NMR (600 MHz, CDCl3): δ 7.46 (br s, 1H), 7.27-7.13 (m, 10H), 6.78 (br s, 1H), 5.16 
(s, 2H), 4.84 (s, 2H), 4.56-4.51 (m, 4H), 0.82 (s, 9H), -0.03 (s, 6H).; 13C NMR (151 MHz, 
CDCl3): δ 165.28, 163.15, 155.15, 158.61, 144.33, 137.16, 136.02, 128.79, 128.51, 128.25, 
128.07, 127.71, 127.47, 127.40, 123.98, 122.35, 120.57, quartet (125.67, 125.46, 123.84, 
123.62, 122.00, 121.78, 120.17, 119.95), 68.22, two quartets overlapped (62.23, 61.99, 
61.75, 61.51, 61.27, 61.02), 54.06, 25.54, 18.10, -4.53.; HRMS (ESI/TOF) m/z calculated 
for C33H35F6NO7SiNa: [M + Na]+ 722.1985; found 722.1959.; IR (neat) cm-1: 2958, 2932, 
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2860, 1751, 1714, 1600, 1400, 1325, 1285, 1251, 1162, 1099,1065, 985, 830, 785, 699.; 
Rf=0.30 (20% ethyl acetate, 80% hexanes). 
Procedure 15: Compound 55 
 
Diene 51a (238 mg, 0.5 mmol, 1.0 equiv.) and methyl propiolate (89 µL, 1.0 mmol, 2.0 
equiv.) were heated at 150 °C in a sealed vial overnight. Purification by gradient column 
chromatography (SiO2, eluent: hexanes to 15% ethyl acetate, 85% hexanes) yielded 55 
(85%) as a light yellow viscous oil. 
1H NMR (600 MHz, CDCl3): δ 7.67 (d, J = 8.4 Hz, 1H), 7.27-7.14 (m, 10H), 6.81 (d, J = 
7.8 Hz, 1H), 6.60 (br s, 1H), 5.16 (s, 2H), 4.85 (s, 2H), 3.80 (s, 3H), 0.90 (s, 9H), 0.01 (s, 
6H).; 13C NMR (151 MHz, CDCl3): δ 166.79, 155.68, 155.25, 146.33, 137.58, 136.29, 
132.17, 128.75, 128.60, 128.19, 127.99, 127.58, 127.52, 119.02, 118.76, 67.85, 54.05, 
51.94, 25.69, 18.30, -4.47.; HRMS (ESI/TOF) m/z calculated for C29H35NO5SiNa: [M + 
Na]+: 528.2182; found 528.2162.; IR (neat) cm-1: 3032, 2951, 2931, 2893, 2858, 1708, 
1604, 1496, 1435, 1392, 1361, 1284, 1253, 1234, 1134, 1087, 972, 956, 837.; Rf=0.60 (20% 
ethyl acetate, 80% hexanes). 
Procedure 16: Compound 56 
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Diene 51a (238 mg, 0.5 mmol, 1.0 equiv.) and 3-butyn-2-one (78 µL, 1.0 mmol, 2.0 
equiv.) were heated at 150 °C in a sealed vial overnight. Purification by gradient column 
chromatography (SiO2, eluent: hexanes to 10% ethyl acetate, 90% hexanes) yielded 56 (194 
mg, 80%) as a light yellow viscous oil. 
1H NMR (600 MHz, CDCl3): δ 7.53 (d, J = 8.4 Hz, 1H), 7.28-7.13 (m, 10H), 6.83 (d, J = 
7.8 Hz, 1H), 6.61 (s, 1H), 5.16 (s, 2H), 4.84 (s, 2H), 2.52 (s, 3H), 0.87 (s, 9H), 0.04 (s, H).; 
13C NMR (151 MHz, CDCl3): δ 199.81, 155.34, 155.26, 146.35, 137.60, 136.30, 130.69, 
128.81, 128.62, 128.24, 128.05, 127.60, 127.38, 118.84, 117.92, 67.91, 54.06, 31.46, 25.92, 
18.51, -4.05.; HRMS (ESI/TOF) m/z calculated for C29H35NO4SiNa: [M + Na]+: 522.2233; 
found 512.2222.; IR (neat) cm-1: 3032, 2954, 2930, 2857, 1712, 1600, 1359, 1315, 1263, 
1231, 1208, 1134, 1068, 965, 835, 784, 699, 668.; Rf=0.60 (20% ethyl acetate, 80% 
hexanes). 
Procedure 17: Compound 57 
 
Diene 51a (238 mg, 0.5 mmol, 1.0 equiv.) and 4-(tert-butyldimethylsilyloxy) but-2-ynal 
(417.5 mg, 2.0 mmol, 4.0 equiv.) were heated at 150 °C in a sealed vial overnight. 
Purification by gradient column chromatography (SiO2, eluent: hexanes to 10% ethyl 
acetate, 90% hexanes) yielded 57 (200 mg, 64%) as a yellow solid. Recovered some of 
CVA 50a (35 mg). 
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1H NMR (600 MHz, CDCl3): δ 10.44 (s, 1H), 7.33 (s, 1H) 7.27-7.15 (m, 10H), 6.65 (br 
s, 1H), 5.18 (s, 2H), 4.99 (s, 2H), 4.92 (s, 2H), 0.92 (s, 9H), 0.85 (s, 9H), 0.08 (s, 6H), 0.03 
(s, 6H).; 13C NMR (151 MHz, CDCl3): δ 191.45, 160.44, 155.12, 148.12, 147.60, 137.57, 
136.20, 128.80, 128.58, 128.21, 128.01, 127.50, 127.07, 121.01, 115.40, 115.26, 67.97, 
63.39, 53.77, 26.08, 25.77, 18.44, 18.41, -4.37, -5.28.; HRMS (ESI/TOF) m/z calculated for 
C35H49NO5Si2Na: [M + Na]+: 642.3047; found 642.3068.; IR (neat) cm-1: 3032, 2954, 2929, 
2856, 1715, 1676, 1597, 1443, 1400, 1390, 1316, 1254,1227, 1177, 1121, 1060, 1027, 833, 
781, 696, 668.; Rf=0.47 (10% ethyl acetate, 90% hexanes). 
Procedure 18: Compound 58 
 
Diene 51a (260 mg, 0.54 mmol, 1.0 equiv.) and 3-bromopropionaldehyde (used crude, 
in excess, contained ethyl acetate) were heated at 150 °C in a sealed vial overnight. 
Purification by gradient column chromatography (SiO2, eluent: hexanes to 10% ethyl 
acetate, 90% hexanes) yielded 58 (121 mg, 40%) as a light brown oil.  Much of the 
remaining balance was isolated as 50a (84 mg, 42%). 
1H NMR (600 MHz, CDCl3): δ 10.29 (s, 1H), 7.37-7.16 (m, 11H), 6.62 (s, 1H), 5.22 (s, 
2H), 4.91 (s, 2H), 0.92 (s, 9H), 0.06 (s, 6H).; 13C NMR (151 MHz, CDCl3): δ 189.37, 
159.29, 154.81, 147.39, 137.06, 135.83, 128.97, 128.71, 128.45, 128.21, 127.79, 127.07, 
124.37, 123.99, 123.18, 116.51, 68.33, 53.71, 25.68, 18.38, -4.43.; HRMS (ESI/TOF) m/z 
calculated for C28H32BrNO4SiNa: [M + Na]+: 576.1182; found 576.1158.; IR (neat) cm-1: 
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3032, 2951, 2931, 1697, 1589, 1543, 1496, 1454, 1388, 1357, 1303, 1222, 1057, 1130, 979, 
837.; Rf=0.68 (10% ethyl acetate, 90% hexanes). 
Procedure 19: Compound 59 
 
Diene 51a (24 mg, 0.05 mmol, 1.0 equiv.) and 3-chloropropionaldehyde (used crude, in 
excess, in ethanol) were heated at 150 °C in a sealed vial overnight.  Purification by gradient 
column chromatography (SiO2, eluent: hexanes to 20% ethyl acetate, 80% hexanes) yielded 
59 (6 mg, 33%) as a bright yellow oil.  The remaining mass balance was collected as 51a 
(18 mg, 67%). 
1H NMR (600 MHz, CDCl3): δ 11.98 (s, 1H), 10.27 (s, 1H), 7.32-7.16 (m, 10H), 7.02 (s, 
1H), 6.74 (s, 1H), 5.22 (s, 2H), 4.95 (s, 2H).; 13C NMR (151 MHz, CDCl3): δ 194.34, 
164.41, 154.59, 150.29, 138.32, 136.86, 135.64, 128.97, 128.73, 128.51, 128.26, 127.78, 
126.87, 118.24, 114.51, 112.04, 68.51, 53.41.; HRMS (ESI/TOF) m/z calculated for 
C22H18ClNO4Na: [M + Na]+: 418.0822; found 418.0807.; IR (neat) cm-1: 3032, 2951, 2931, 
2858, 1728, 1712, 1431, 1396, 1369, 1323, 1257, 1242, 1211, 1165, 1111, 1060, 1010, 960, 
887, 840.; Rf=0.35 (20% ethyl acetate, 80% hexanes). 
Procedure 20: Compound 60a and 60b 
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Diene 51a (621 mg, 1.30 mmol, 1.0 equiv.) and 4-oxo-hex-2-ynoic acid methyl ester 
(366 mg, 2.6 mmol, 2.0 equiv.) were heated at 150 °C in a sealed vial overnight.  
Purification by gradient column chromatography (SiO2, eluent: hexanes to 20% ethyl 
acetate, 80% hexanes) yielded 60a & 60b (2:1, 487 mg, 67% combined yield) as light 
yellow viscous oils. 
60a: 1H NMR (600 MHz, CDCl3): δ 7.47 (br s, 1H), 7.32-7.16 (m, 10H), 6.67 (br s, 1H), 
5.19 (s, 2H), 4.86 (s, 2H), 3.80 (s, 3H), 2.76 (q, J = 7.2 Hz, 2H), 1.16 (t, J = 7.2 Hz, 3H), 
0.85 (s, 9H), -0.03 (s, 6H).; 13C NMR (151 MHz, CDCl3): δ 205.93, 165.70, 155.33, 152.19, 
142.68, 137.40, 136.24, 134.61, 128.81, 128.76, 128.59, 128.24, 128.06, 127.70, 127.67, 
121.95, 121.05, 67.91, 54.17, 52.57, 37.36, 25.56, 18.07, 7.44, -4.54.; HRMS (ESI/TOF) 
m/z calculated for C32H39NO6SiNa: [M + Na]+: 584.2444; found 584.2417.; IR (neat) cm-1: 
3032, 2951, 2935, 2858, 1712, 1600, 1438, 1396, 1369, 1319, 1253, 1165, 1130, 1064, 
1030, 964, 833, 786, 732, 698.; No Rf obtained, less polar than 60b. 
60b: 1H NMR (600 MHz, CDCl3): δ 7.34-7.19 (m, 11H), 6.70 (br s, 1H), 5.20 (s, 2H), 
4.86 (s, 2H), 3.87 (s, 3H), 2.69 (q, J = 6.6 Hz, 2H), 1.09 (t, J = 7.2 Hz, 3H), 0.89 (s, 9H), 
0.02 (s, 6H).; 13C NMR (151 MHz, CDCl3): δ 200.07, 168.23, 155.29, 153.60, 143.49, 
137.41, 136.92, 136.13, 128.91, 128.69, 128.40, 128.28, 127.84, 127.76, 123.91, 121.28, 
119.83, 68.04, 54.24, 52.52, 32.65, 25.51, 18.09, 8.08, -4.49.; HRMS (ESI/TOF) m/z 
calculated for C32H39NO6SiNa: [M + Na]+: 584.2444; found 584.2421.; IR (neat) cm-1: 
3032, 2951, 2935, 2893, 2858, 1712, 1600, 1438, 1396, 1369, 1319, 1253, 1165, 1130, 
1064, 1030, 964, 833, 786, 698.; No Rf obtained, more polar than 60a. 
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Procedure 21: Compound 61 
 
Diene 51a (238 mg, 0.5 mmol, 1.0 equiv.) and ethyl cyanoformate (494 µL, 5.0 mmol, 
10.0 equiv.) were heated at 150 °C in a sealed vial overnight. Purification by gradient 
column chromatography (SiO2, eluent: hexanes to 10% ethyl acetate, 90% hexanes) yielded 
61 (158 mg, 61%) as a light pink viscous oil. This product tautomerizes to pyridone 64 
easily. 
1H NMR (600 MHz, CDCl3): δ 7.67 (s, 1H), 7.38-7.19 (m, 10H), 6.81 (s, 1H), 5.23 (s, 
2H), 4.98 (s, 2H), 4.34 (q, J = 6.6, 7.2, 2H), 1.36 (t, J = 7.2, 3H), 0.97 (s, 9H), 0.33 (s, 6H).; 
13C NMR (151 MHz, CDCl3): δ 165.07, 163.35, 154.62, 152.74, 146.48, 137.07, 135.71, 
128.85, 128.64, 128.37, 128.15, 127.62, 126.93, 114.60, 111.28, 68.33, 61.50, 52.92, 26.06, 
18.18, 14.27, -4.18.; HRMS (ESI/TOF) m/z calculated for C29H36N2O5SiNa: [M + Na]+: 
543.2291; found 543.2274.; IR (neat) cm-1: 2956, 2930, 2899, 2857, 1718, 1598, 1558, 
1436, 1387, 1332, 1249, 1153, 1032, 698, 668.; Rf=0.65 (20% ethyl acetate, 80% hexanes). 
Procedure 22: Compound 62 
 
KHMDS (0.05 mmol, 0.917 M in THF) was added to a flame-dried round bottom flask 
under a nitrogen atmosphere and cooled to -78 °C. A mixture of 60a and 60b were 
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azeotroped twice in toluene and diluted in THF and 4Å molecular sieves were added. This 
solution was cannulated slowly to the base and rinsed twice with THF (20 mL total THF). 
The solution was allowed to warm to room temperature and quenched with 1M HCl. The 
reaction mixture was extracted twice with ethyl acetate, washed twice with water, once with 
brine and dried over Na2SO4. The combined organics were then filtered and concentrated to 
yield 15 mg of the product 62 in a 76% yield. 
1H NMR (500 MHz, CDCl3): δ 8.60 (s, 1H), 7.35-7.13 (m, 12H), 5.22 (s, 2H), 4.99 
(s, 2H), 3.04 (q, J = 8 Hz, 1H), 1.38 (d, J = 8 Hz, 3H).; 13C NMR (151 MHz, CDCl3): δ 
203.41, 199.67, 156.81, 154.67, 151.59, 142.07, 136.60, 135.55, 128.81, 128.57, 128.35, 
128.12, 127.69, 126.94, 123.44, 119.15, 111.96, 68.35, 53.64, 49.07, 10.52.; HRMS 
(ESI/TOF) m/z calculated for C25H21NO5Na: [M + Na]+: 438.1317; found 438.1304.; IR 
(neat) cm-1: 3371, 2924, 2854, 1739, 1693, 1620, 1477, 1454, 1396, 1307, 1226, 1130, 759, 
740, 698. 
Procedure 23: Compound 63 
 
tert-Butyldimethylsilyl-protected m-APhOH 53 (65 mg, 0.115 mmol) and Pd/C (4 mg, 6 
wt%) were transferred using EtOAc (5 mL) into a flask fitted with a T-valve. It was purged 
of air and attached to an H2 balloon and allowed to stir at rt for 19h. The crude product was 
filtered over a celite plug to yield 63 (37 mg, 96%) as a bright yellow oil. 
NH2
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1H NMR (500 MHz, CDCl3): δ 6.83 (d, J = 2 Hz, 1H), 6.27 (d, J = 2 Hz, 1H), 3.83 (s, 
3H), 3.82 (s, 3H), 0.96 (s, 9H), 0.21 (s, 6H), [NH2 not found]; 13C NMR (151 MHz, CDCl3): 
δ 168.22, 166.34, 154.02, 148.09, 130.47, 117.80, 109.15, 109.94, 52.38, 52.18, 25.48, 
18.02, -4.48.; HRMS (ESI/TOF) m/z calculated for C16H25NO5SiNa: [M + Na]+: 362.1400; 
found 362.1385.; IR (neat) cm-1: 3474, 3380, 2951, 2930, 2898, 2858, 1726, 1604, 1455, 
1434, 1365, 1271, 1261, 1219, 1193, 1168, 1096, 1041, 1005, 919, 837, 784.; No Rf value 
determined. 
Procedure 24: Compound 64 
 
tert-butyldimethylsilyl-protected m-APyOH 61 (75 mg, 0.144 mmol, 1 equiv.), SiO2 (4 
g), H2SO4 (0.5 mL), and THF (30 mL) were concentrate on a rotary evaporator in vacuo 
(<15 mmHg) at 40 °C for 15 minutes. The solid was washed through a filter frit plugged 
with SiO2 using EtOAc. The resultant organic layer was washed with brine, dried over 
Na2SO4 and filtered. Removal of the solvent yielded 64 (53 mg, 90%) without any further 
purification. 
1H NMR (600 MHz, CDCl3): δ 9.84 (br s, 1H), 7.31-7.08 (m, 11H), 6.39 (s, 1H), 5.18 (s, 
2H), 4.89 (s, 2H), 4.32 (q, J = 7.2 Hz, 2H), 1.30 (t, J = 7.2 Hz, 3H).; 13C NMR (151 MHz, 
CDCl3): δ 163.01, 160.81, 154.28, 153.14, 136.38, 135.35, 133.02, 129.02, 128.72, 128.60, 
128.37, 127.79, 126.58, 116.08, 108.57, 68.75, 63.04, 52.90, 14.24.; HRMS (ESI/TOF) m/z 
calculated for C23H22N2O5Na: [M + Na]+: 429.1426; found 429.1406.; IR (neat) cm-1: 3032, 
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2982, 2938, 1721, 1716, 1651, 1645, 1496, 1455, 1422, 1389, 1355, 1264, 1212, 1136, 
1058, 1028, 913, 861, 770, 733, 698.; No Rf value determined. 
Kinetic Diene Aromatic Diels-Alder & retro-Diels-Alder Products 
General Procedure: Diene 52a was prepared and stored in benzene frozen until needed 
for use. For the following reactions, 52a (0.14 M in benzene) and the corresponding 
acetylene (≥2 equiv., neat) were added to a sealed tube using the outlined general conditions 
for sealed tube reactions. Each vial was then heated at 150 °C for 12-16h (although 
reactions were probably complete after 5-8h). The contents were diluted in EtOAc, 
transferred to a RBF and concentrated in vacuo. The crude contents were then purified by 
gradient column chromatography (SiO2, eluent: varying solvent conditions) to afford 
products 65-69. 
Procedure 25: Compound 65 
 
Diene 52a (111 mg, 0.234 mmol, 1 equiv.) and dimethylacetylenedicarboxylate (57 µL, 
0.468 mmol, 2 equiv.) were heated at 150 °C in a sealed vial overnight. Purification by 
column chromatography (SiO2, eluent: dichloromethane) yielded 65 and 53 (106 mg, 80%, 
combined yield) as a 2:1 mixture of products. The mixture was difficult to separate, so 
treatment with TBAF facilitated separation of the corresponding phenols by gradient 
column chromotography (SiO2: hexanes to 30% ethyl acetate, 70% hexanes). The 
corresponding phenol, 65-OH (24 mg, 0.053 mmol, 1.0 equiv.) was then submitted to 
reaction with DBU (8.8 µL, 0.058 mmol, 1.2 equiv.) in dichloromethane (5 mL, 0.01 M) and 
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stirred for 5 min. The intermediate phenoxide was protected with tert- butyldimethylsilyl 
chloride (10.4 mg, 0.069 mmol, 1.3 equiv.) and stirred for 1hour. The product was extracted 
3x CH2Cl2, dried over Na2SO4, filtered and concentrated. The product was then purified 
using gradient column chromotography (SiO2, eluent: hexanes to 12% ethyl acetate, 82% 
hexanes) and isolated to give 65 (24 mg, 80%) and characterized as such. 
1H NMR (500 MHz, C6D6, T=70 °C) δ 7.48 (s, 1H), 7.23-6.98 (m, 10H), 6.52 (br s, 1H), 
5.71 (br, 1H), 5.14 (q, 2H), 4.36 (br, 1H), 3.59 (3H), 3.34 (s, 3H), 0.81 (s, 9H), -0.14 (s, 
6H). Data here for unresolved peaks, VT spectrum of 65 included in spectra section.; 13C 
NMR (151 MHz, solvent) δ 167.69, 165.96, 165.02, 156.61, 155.71, 140.14, 137.42, 136.59, 
131.18, 129.16, 128.70, 128.42, 127.86, 127.76, 127.57, 125.62, 121.27, 67.68, 54.18, 
52.85, 52.78, 25.60, 18.20, -4.54.; HRMS (ESI/TOF) m/z calculated for C31H37NO7SiNa: [M 
+ Na]+: 586.2237; found 586.2209.; IR (neat) cm-1: 3032, 2955, 2850, 1716, 1643, 1620, 
1562, 1492, 1454, 1423, 1388, 1307, 1215, 1130, 1049, 976, 868, 848.; Rf=0.54 (30% ethyl 
acetate, 70% hexanes). 
Procedure 26: Compound 66 
 
Diene 52a (125 mg, 0.261 mmol, 1.0 equiv.) and bis(2,2,2-trifluoroethyl) 
acetylenedicarboxylate (145 mg, 0.522 mmol, 2 equiv.) were heated at 150 °C in a sealed 
vial overnight.  Purification by gradient column chromatography (SiO2, eluent: hexanes to 
15% ethyl acetate, 85% hexanes) yielded 66 and 54 (108 mg, 59%, combined yield) as a 
>4:1 mixture of products. 
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1H NMR (500 MHz, T=70 °C, C6D6) δ 7.36 (d, J = 2 Hz, 1H), 7.19-7.00 (m, 10H), 6.52 
(s, 1H), [br, 2H, too broad to see in VT,], 4.36 (q, J = 8.5 Hz, 2H), 4.10 (q, J = 8.5 Hz, 2H), 
0.79 (s, 9H), -0.10 (s, 6H). Spectra from before and after VT included.; 13C NMR (200 
MHz, T=70 °C, C6D6) δ 165.43, 163.95, 158.01, 155.88, 142.57, 138.31, 137.35, 130.85, 
129.72, 129.21, 128.93, 128.74, 128.69, 128.63, 127.20, 127.08, 2xC split by F (126.13, 
125.82, 124.75, 124.44, 123.37, 123.06), 121.78, 68.53, 2xC quartets (62.43, 62.25, 62.07, 
61.97, 61.88, 61.78, 61.60, 61.42), 55.02, 25.94, 18.59, -4.27.; [peaks near C6D6 solvent 
may not be assigned correctly due to solvent interference].; HRMS (ESI/TOF) m/z 
calculated for C33H35F6NO7SiNa: [M + Na]+: 722.1985; found 722.1957.; IR (neat) cm-1: 
3032, 2955, 2931, 2885, 2858, 1712, 1681, 1597, 1469, 1396, 1361, 1311, 1253, 1168, 
1111, 1060, 1006, 837, 779, 732, 698.; Rf=0.50 (20% ethyl acetate, 80% hexanes). 
Procedure 27: Compound 67 
 
Diene 52a (163 mg, 0.34 mmol, 1.0 equiv.) and methyl propiolate (69 µL, 0.68 mmol, 2 
equiv.) were heated at 150 °C in a sealed vial overnight. Purification by gradient column 
chromatography (SiO2, eluent: hexanes to 15% ethyl acetate, 85% hexanes) yielded 67 and 
55 (94 mg, 62%, combined yield) as a >4:1 mixture of products. 
1H NMR (600 MHz, C6D6) δ 7.98 (d, J = 9 Hz, 1H), 7.27-6.97 (m, 10H), 6.58-6.57 (m, 
1H), 6.51 (d, J = 2.4 Hz, 1H), 5.58 (d, J = 15.6 Hz, 1H), 5.20 (d, J = 12.6 Hz, 1H), 5.02 (d, J 
= 13.2 Hz, 1H), 4.24 (d, J = 15 Hz, 1H), 3.38 (s, 3H), 0.84 (s, 9H), -0.11 (d, J = 6 Hz, 6H).; 
13C NMR (125 MHz, d7-DMF) δ 166.53, 160.51, 156.50, 139.30, 138.37, 134.04, 129.74, 
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129.46, 129.37, 128.82, 128.59, 128.47, 122.93, 122.76, 120.02, 68.08, 55.51, 26.69, 26.36, 
26.35, 19.07, -3.92.; HRMS (ESI/TOF) m/z calculated for C29H35NO5SiNa: [M + Na]+: 
528.2182; found 528.2164.; IR (neat) cm-1: 3032, 2951, 2931, 2858, 1712, 1600, 1566, 
1496, 1435, 1396, 1357, 1303, 1278, 1257, 1192, 1126, 1095, 956, 840, 810.; Rf=0.48 (20% 
ethyl acetate, 80% hexanes). 
Procedure 28: Compound 68 
 
Diene 52a (120 mg, 0.251 mmol, 1.0 equiv.) and but-3-yne-2-one (40 µL, 0.502 mmol, 
2 equiv.) were heated at 150 °C in a sealed vial overnight. Purification by gradient column 
chromatography (SiO2, eluent: hexanes to 20% ethyl acetate, 80% hexanes) yielded 68 and 
56 (70 mg, 57%) as a >4:1 mixture of products. Compound 68 was characterized as the 
corresponding phenol. 
1H NMR (600 MHz, CDCl3) δ 12.31 (s, 1H), 7.62 (d, J = 9Hz, 1H), 7.32-7.18 (m, 10H), 
6.83 (s, 1H), 6.82 (s, 1H), 5.21 (s, 2H), 4.94 (s, 2H), 2.57 (s, 3H).; 13C NMR (151 MHz, 
CDCl3) δ 203.43, 163.05, 154.86, 149.24, 137.26, 135.92, 131.01, 128.63, 128.48, 128.14, 
127.94, 127.42, 127.05, 117.29, 116.65, 114.25, 67.93, 53.55, 26.53.; HRMS (ESI/TOF) m/z 
calculated for C23H21NO4Na: [M + Na]+: 398.1368; found 398.1349.; IR (neat) cm-1: 3063, 
3032, 2924, 2850, 1708, 1639, 1573, 1496, 1454, 1392, 1365, 1323, 1273, 1226, 1130, 
1076, 1033, 968, 806, 732, 698.; Rf=0.19 (20% ethyl acetate, 80% hexanes). 
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Procedure 29: Compound 69 
 
Diene 52a (163 mg, 0.34 mmol, 1.0 equiv.) and 4-(tert-butyldimethylsilyloxy) but-2-
ynal (105.4 mg, 0.53 mmol, 1.56 equiv.) were heated at 150 °C in a sealed vial overnight. 
Purification by gradient column chromatography (SiO2, eluent: hexanes to 10% ethyl 
acetate, 90% hexanes) yielded 69 and 57 (87 mg, 41%, combined yield) as a >4:1 mixture of 
products. 
1H NMR (500 MHz, C6D6, T=70 °C) δ 10.13 (s, 1H), 7.54 (s, 1H), 7.16-7.07 (m, 10H), 
6.47 (s, 1H), 5.26 (s, 2H), 5.04 (s, 2H), 4.62 (br, 2H), 0.98 (s, 9H), 0.92 (s, 9H), 0.08 (s, 
6H), 0.06 (s, 6H).; 13C NMR (200 MHz, T=70 °C, C6D6) δ 189.70, 160.97, 155.69, 148.67, 
137.41, 137.00, 129.37, 128.76, 128.58, 128.30, 128.24, 128.07, 127.95, 127.64, 124.12, 
119.20, 117.78, 67.97, 63.64, 55.71, 26.17, 25.71, 18.53, 18.34, -4.35, -5.34.; [peaks near 
C6D6 solvent may not be assigned correctly due to solvent interference]. HRMS (ESI/TOF) 
m/z calculated for C35H49NO5Si2Na: [M + Na]+: 642.3047; found 642.3024.; IR (neat) cm-1: 
2955, 2931, 2858, 2831, 1751, 1716, 1600, 1400, 1369, 1327, 1288, 1249, 1168, 1107, 
1072, 1033, 968, 837, 810, 786, 702.; Rf=0.29 (10% ethyl acetate, 90% hexanes). 
Preparation of Deuterated Materials 
Procedure 30: Compound 50d 
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Deuterated (80%) CVA 50d was formed by deprotonation of 50a using KHMDS under 
equilibrating conditions. CVA 50a (1.3 equiv.) was azeoptroped 3x in toluene and diluted in 
THF with 4Å molecular sieves. This solution was cannulated to a flame-dried RBF and 
cooled to 0 °C. KHMDS (1.0 equiv.) was added slowly and the resultant solution was stirred 
at 0 °C for 5h. tert-Butyldimethylsilyl chloride (1.4 equiv.) was added by cannula in THF 
and the solution was allowed to warm to rt to give the corresponding t-D- 51a. The reaction 
mixture was concentrated and the diene was purified in the usual manner, through a solution 
of 3% Et3N, 5% ethyl acetate, 93% hexanes. The diene was stirred with d4-acetic acid to 
give the deuterated CVA 50d. This was repeated a total of four times to incorporate 
deuterium at the desired position in 80%. The product was purified using gradient column 
chromatography (SiO2: hexanes to 30% ethyl acetate, 70% hexanes). 
1H NMR (600 MHz, CDCl3) δ 7.33-7.13 (m, 10H), 5.75 (s, 1H), 5.2 (s, 2H), 4.87 (s, 
2H), 2.56 (br d, deuterium incorporated, 0.30, 2D/H), 2.17 (s, 2H), 0.93 (s, 6H).; 13C NMR 
(151 MHz, CDCl3) δ 199.49, 160.27, 154.02, 136.61, 135.22, 128.72, 128.54, 128.50, 
128.34, 127.48, 126.51, 120.49, 116.63, 68.52, 52.72, 50.46, 33.80, 27.87.; No HRMS 
obtained.; IR (neat) cm-1: 3032, 2958, 2870, 1716, 1658, 1597, 1496, 1454, 1396, 1354, 
1307, 1273, 1207, 1126, 999, 960.; Rf=0.47 (30% ethyl acetate, 70% hexanes). 
Procedure 31: Compound 52d 
 
Deuterated diene 52d was formed by using the modified Schlosser's conditions to form 
kinetic diene 52d. Deuterated 50d was azeotroped 3x in toluene and diluted in THF, then 
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put over 4Å molecular sieves. To a RBF with KOtBu (92 mg, 0.823 mmol, 1.5 equiv.) was 
added THF. This solution was cooled to -78 °C and n-BuLi (0.316 mL, 0.823 mmol, 1.5 
equiv.) was added. The solution of 50d was cannulated into the cooled base solution when 
TBS-Cl (165 mg, 1.098 mmol, 2.0 equiv.) was cannulated into the enolate solution after 10 
minutes. The solution was allowed to warm to rt and then concentrated. The solution was 
diluted in 50 mL of 3% Et3N, 5% ethyl acetate, 93% hexanes and filtered through a pad of 
silica to form 52d in good yield. 
1H NMR (500 MHz, CDCl3) δ 7.21-7.01 (m, 10H), 5.6 (d, J = 1.5 Hz, 1H), 5.11 (s, 2H), 
4.65 (d, J = 1.5 Hz, 1H), 4.60 (s, 2H), 0.93 (s, 9H), 0.67 (s, 6H).; No 13C data, HRMS, IR or 
Rf data obtained due to the compound sensitivity; used crude. 
The general procedure for the tandem Diels-Alder and retro-Diels-Alder reactions was 
used to afford a mixture of compounds 65 and 53d. A spectrum of the mixture of 65:53d is 
included with the spectra. 
Method Application Towards Tetrapetalone A 
Procedure 32: Compound 75 
 
A pressure tube was charged with dimedone (5.6 g, 40.1 mmol, 1 equiv.), glycine 
methyl ester hydrochloride (5.5 g, 40.1 mmol, 1 equiv.) and Na2SO4 (11.4 g, 80.2 mmol, 2 
equiv.) in toluene (67 mL) and DIPEA (7.3 mL, 42.1 mmol, 1.05 equiv.) was added. The 
tube was purged with N2 and sealed, then placed in an oil bath at 130 ºC, and stirred for 3h. 
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The reaction mixture was washed with 5% HCl, saturated aqueous NaHCO3 and brine. The 
organic fraction was dried with Na2SO4, filtered and concentrated to yield the crude product. 
Trituration with 5% ethyl acetate, 95% hexanes afforded the pure product 75 (8.1 g, 90%) 
which matched known characterization data. 
1H NMR (500 MHz, CDCl3): δ 5.01 (s, 1H), 4.98 (br s, 1H), 3.84 (d, J = 4.5 Hz, 2H), 
3.81 (s, 3H), 2.25 (s, 2H), 2.19 (s, 2H), 1.07 (s, 6H).; Spectrum not included. 
Procedure 33: Compound 76 
 
To a solution of the compound 75 in THF (47.0 mL, 0.2 M, 1.0 equiv.) was added n- 
BuLi (4.07 mL, 2.56 M, 1.1 equiv.) at -78 ºC. After stirring at this temperature for 20 min, 
2-bromopropionyl bromide (1.5 mL, 14.22 mmol, 1.5 equiv.) was added dropwise. The 
reaction mixture was stirred and warmed slowly to room temperature over 12 h before it 
was quenched with saturated aqueous NaHCO3. The solution was extracted with EtOAc, 
and the combined organic solutions were washed with brine, dried with MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography (SiO2, eluent: 
hexanes-ethyl acetate = 7/1 to 2/1) to afford product 76 (1.68 g, 4.86 mmol, 51%) as a 
yellow oil. 
1H NMR (500 MHz, CDCl3): δ 5.97 (s, 1H), 4.63 (q, J = 6.6 Hz, 1H), 4.23 (d, J = 17.5 
Hz, 1H), 4.12 (d, J = 17.6 Hz, 1H), 3.70 (s, 3H), 2.52 (d, J = 18.2 Hz, 1H), 2.41 (d, J = 18.3 
Hz, 1H), 2.25 (s, 2H), 1.75 (d, J = 6.6 Hz, 3H), 1.07 (s, 3H), 1.05 (s, 3H).; 13C NMR (126 
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MHz, CDCl3): δ 198.8, 169.2, 168.4, 158.4, 124.9, 52.6, 50.7, 48.8, 42.4, 38.1, 33.3, 28.1, 
27.9, 21.6.; HRMS (FI) m/z calculated for C14H20BrNO4Na: [M + Na]+ 368.0473; found 
368.0484. IR (neat) cm-1: 2959, 2870, 1751, 1670, 1628, 1385, 1207, 1015.; Rf=0.08 (20% 
ethyl acetate, 80% hexanes). 
Procedure 34: Compound 77 
 
A flask charged with acyl bromide 76 (1.0 g, 2.89 mmol, 1 equiv.), CHI3 (2.32 g, 5.89 
mmol, 2.0 equiv.) and Sm (1.46g, 9.73 mmol, 3.3 equiv.), was fitted with a reflux condenser 
and thoroughly purged with N2. THF (60 mL) was sparged with N2 and added into the flask. 
The reaction mixture was brought to reflux until TLC analysis revealed complete 
consumption of starting material before it was quenched with 0.5 M HCl. The solution was 
extracted with EtOAc, and the combined organic solutions were washed with brine, dried 
with MgSO4, and concentrated in vacuo. To a solution of this residue in Et2O (29 mL, 0.1 
M, 1 equiv.) was added CH2N2 (58 mL, 0.4 M, 8 equiv.) at 0 ºC. The mixture was stirred at 
this temperature for 3 h, and quenched with 0.5 M AcOH. Then the solution was extracted 
with EtOAc, and the combined organic solutions were washed with brine, dried with 
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography 
(SiO2, eluent: 33% ethyl acetate, 66% hexanes) to afford product 77 (0.58 g, 2.34 mmol, 
81%) as a yellow solid. 
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mp=149-152 °C.; 1H NMR (600 MHz, CDCl3): δ 5.45 (s, 1H), 4.02 (s, 2H), 3.94 (s, 3H), 
3.02 (s, 2H), 2.16 (s, 2H), 1.74 (s, 3H), 1.02 (s, 6H).; 13C NMR (151 MHz, CDCl3): δ 199.1, 
172.2, 166.1, 156.9, 106.0, 105.6, 57.6, 50.3, 47.8, 40.3, 33.0, 28.4, 6.8.; HRMS (FI) m/z 
calculated for C14H19NO3Na: [M + Na]+ 272.1263; found 272.1250.; IR (neat) cm-1: 2924, 
2851, 1740, 1667, 1458, 1373, 1242, 1045.; Rf=0.15 (50% ethyl acetate, 50% hexanes). 
Procedure 35: Compound 78 
 
To a solution of the compound 77 (180 mg, 0.72 mmol, 1 equiv.) and HMPA (0.63 mL, 
3.61 mmol, 5 equiv.) in THF (13.6 mL, 0.05 M) was added KHMDS (0.87 mL, 1.0 M, 1.2 
equiv.) at -78 ºC. After stirring at this temperature for 1 h, MeI (0.36 mL, 5.76 mmol, 8 
equiv.) was added dropwise. The reaction mixture was kept at this temperature for 6 h and 
then warmed slowly to room temperature over 12 h before it was quenched with saturated 
aqueous NH4Cl. The solution was extracted with EtOAc, and the combined organic 
solutions were washed with brine, dried with MgSO4, and concentrated in vacuo. The 
residue was purified by column chromatography (SiO2, eluent: 16% ethyl acetate, 84% 
hexanes to 50% ethyl acetate, 50% hexanes) to afford product 77’ (167 mg, 0.63 mmol, 
88%) as a yellow oil. 
1H NMR (600 MHz, CDCl3): δ 5.33 (s, 1H), 4.12 (q, J = 6.3 Hz, 1H), 4.02 (s, 3H), 3.19 
(d, J = 18.2 Hz, 1H), 2.72 (d, J = 18.1 Hz, 1H), 2.16 (q, J = 12.8 Hz, 2H), 1.88 (s, 3H), 1.30 
(d, J = 6.5 Hz, 3H), 1.04 (s, 3H), 0.98 (s, 3H).; 13C NMR (151 MHz, CDCl3): δ 199.1, 
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172.0, 170.6, 155.8, 108.6, 102.5, 58.8, 54.6, 50.3, 41.2, 33.4, 29.3, 27.2, 16.4, 7.9.; HRMS 
(FI) m/z calculated for C15H21NO3Na: [M + Na]+ 286.1419; found 286.1415.; IR (neat) cm-1: 
2955, 1655, 1586, 1458, 1377, 1250, 1076, 1030.; Rf=0.20 (50% ethyl acetate, 50% 
hexanes). 
The procedure to prepare compound 78 is similar to the one to yield compound 77’, 
during which the allyl bromide (13.5 equiv.) was used instead of MeI. The crude product 
was purified by gradient column chromatography (SiO2, eluent: 16% ethyl acetate, 84% 
hexanes to 50% ethyl acetate, 50% hexanes) to afford 78 as a yellow oil in 38% yield (52% 
based on recovery of starting material). 
1H NMR (500 MHz, CDCl3): δ 5.73 (s, 1H), 5.33-5.28 (m, 1H), 5.01-4.97 (m, 2H), 4.08 
(s, 3H), 2.90 (q, J = 13.8 Hz, 2H), 2.76 (dd, J = 14.8, 6.8 Hz, 1H), 2.47 (dd, J = 14.7, 7.1 
Hz, 1H), 2.21 (s, 2H), 1.96 (s, 3H), 1.48 (s, 3H), 1.05 (s, 3H), 1.03 (s, 3H).; 13C NMR (126 
MHz, CDCl3): δ 199.6, 172.3, 171.6, 156.3, 130.9, 119.1, 111.1, 101.9, 66.8, 59.1, 50.2, 
42.4, 38.5, 33.6, 28.4, 28.1, 23.2, 8.1.; HRMS (FI) m/z calculated for C18H25NO3Na: [M + 
Na]+ 326.1732; found 326.1727. IR (neat) cm-1: 2955, 1709, 1670, 1589, 1362, 1281, 1238, 
1099.; Rf=0.21 (25% ethyl acetate, 75% hexanes). 
Procedure 36: Compound 79 
 
CVA 78 was azeotroped 3x in toluene, diluted in THF and put over 4Å molecular 
sieves. KHMDS (0.94 M, 0.114 mL, 0.107 mmol, 1.3 equiv.) in THF was cooled to -78 °C.  
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The THF solution of 78 was cannulated into the base and stirred for 5 min. The enolate was 
protected with TBS-Cl (24.83 mg, 0.1648 mmol, 2.0 equiv.) by cannulation in THF. The 
resultant reaction mixture was allowed to warm to rt over 5h. The solution was 
concentrated, diluted in ether and filtered over celite. The solution was concentrated to 
afford the diene 79 (73%-97%), which was used crude. 
1H NMR (500 MHz, CDCl3) δ 5.56 (s, 1H), 5.51-5.43 (m, 1H), 5.04-4.98 (m, 2H), 4.63 
(d, J = 1.5 Hz, 1H), 4.02 (s, 3H), 2.51-2.38 (m, 3H), 2.23-2.24 (dd, J = 1.5, 15.5 Hz, 1H), 
1.96 (s, 3H), 1.32 (s, 3H), 1.06 (s, 3H), 1.04 (s, 3H), 0.85 (s, 9H), -0.01 (s, 6H).; No 13C, 
HRMS, IR or Rf data taken due to the diene sensitivity. The acid sensitive compound was 
used crude. 
Procedure 37: Compound 86 
 
Diene 79 was subjected to Diels-Alder reaction conditions with DMAD (15 µL, 0.1197 
mmol, 2 equiv.) and benzene (2 mL). The mixture was heated at 150 °C for 12h to yield a 
regioisomeric mixture of phenolic products in a 2:1 ratio. The major product was the 
desired isomer and the corresponding thermodynamic aromatic product was the minor 
product. The products were purified by column chromatography (SiO2, eluent: hexanes to 
60% ethyl acetate, 40% hexanes) to yield 86 and the thermodynamic isomer 86b (20 mg, 
85%, combined yield). 
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86: 1H NMR (500 MHz, C6D6, T=70 °C) δ 7.44 (S, 1H), 6.50 (S, 1H), 5.76-5.68 (m, 
1H), 5.05-3.94 (m, 2H), 3.61 (s, 3H), 3.51 (s, 3H), 3.42 (s, 3H), 2.42-2.24 (m, 2H), 1.86 (s, 
3H), 1.25 (s, 3H).; 13C NMR (151 MHz, CDCl3) δ 173.74, 171.02, 167.14, 166.73, 158.95, 
134.14, 133.14, 131.87, 125.14, 121.81, 118.87, 117.56, 100.70, 67.17, 58.86, 52.49, 52.36, 
40.33, 20.69, 8.16.; HRMS (ESI/TOF) m/z calculated for C20H23O7N: [M + Na]+ 412.1372; 
found 412.1366.; IR (neat) cm-1: 3132, 3078, 3001, 2951, 2252, 1732, 1651, 1608, 1435, 
1392, 1334, 1265, 1234, 1145, 991, 918.; Rf=0.14 (60% ethyl acetate, 40% hexanes). 
86 as phenol methyl ester (86-ME): 1H NMR (600 MHz, CDCl3) δ 7.28 (s, 1H), 6.92 
(s, 1H), 5.68-5.61 (m, 1H), 5.16-5.08 (m, 2H), 4.08 (s, 3H), 3.86 (s, 3H), 3.83 (s, 3H), 3.74 
(s, 3H), 2.54-2.53 (m, 2H), 2.02 (s, 3H), 1.29 (s, 3H). 
86b: 1H NMR (600 MHz, CDCl3) δ 10.68 (s, 1H), 7.21 (s, 1H), 7.06 (s, 1H), 5.46-5.39 
(m, 1H), 5.017-4.96 (m, 2H), 4.10 (s, 3H), 3.90 (s, 3H), 3.86 (s, 3H), 2.56-2.48 (m, 2H), 
2.03 (s, 3H), 1.44 (s, 3H).; 13C NMR (151 MHz, CDCl3) δ 172.28, 170.35, 169.98, 161.83, 
143.18, 138.21, 135.99, 131.27, 119.05, 116.45, 114.29, 106.84, 101.61, 66.32, 58.98, 
52.77, 52.61, 39.67, 23.87, 8.19.; HRMS (ESI/TOF) m/z calculated for C20H23O7N: [M + 
Na]+ 412.1372; found 412.1362. No IR data obtained.; Rf=0.23 (60% ethyl acetate, 40% 
hexanes). 
Preparation of Acetylenic Dienophiles 
Procedure 38: Acetylene bis(2,2,2-trifluoroethyl) but-2-ynedioate 
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Acetylene A was prepared by modification of a previous procedure and the product was 
confirmed with the known 1H and 13C data.49 Butynedioic acid (1.5 g, 13.15 mmol, 1 
equiv.), BF3OEt2 (3.5 mL, 27.62 mmol, 2.1 equiv.) and 2,2,2-trifluoroethanol were added 
to a RBF fitted with a reflux condenser. The solution was refluxed at 80 °C for 3.5h and 
then stirred overnight at rt. The reaction mixture was diluted in Et2O and washed with water 
multiple times, then with brine. The acetylene A was used in crude form with >90% purity 
and stored frozen as a solution in benzene. 
Rf=0.45 (10% ether, 90% hexanes). 
Procedure 39: Acetylene 4-((tert-butyldimethylsilyl)oxy)but-2-ynal 
 
B was prepared from 4-(tert-butyldimethylsilyloxy) but-2-yn-1-ol (B-1). The mono- 
protected diol was prepared by a known procedure and compared with known 1H and 13C 
values.50 Oxidation to the aldehyde B was done by modifying a known procedure that uses 
Dess-Martin Periodinane.51 As an alternative to DMP, we use IBX, prepared using oxone.52 
Mono-protected diol B-1 (273 mg, 1.37 mmol, 1.0 equiv.), IBX (422 mg, 1.507 mmol, 1.1 
equiv.) and EtOAc (10 mL) were added to a 50 mL RBF fitted with a reflux condenser and 
refluxed at 80 °C for 7h. The reaction was then filtered over a frit and concentrated in 
vacuo. The crude reaction mixture was purified by column chromatography (SiO2, eluent: 
hexanes to 5% ethyl acetate, 95% hexanes) to afford the product B (232 mg, 85%) as a pure 
oil which was stored frozen as a solution in benzene. 
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Procedure 40: Acetylene methyl-4-oxohex-2-ynoate 
 
C was prepared from methyl 4-hydroxyhex-2-ynoate (C-1) which was prepared from a 
known literature procedure.53 Propargyllic alcohol C-1 using an adaptation from a known 
procedure which uses DMP.54 Alcohol C-1 (1.015 g, 7.14 mmol, 1.0 equiv.), IBX (3.0 g, 
10.71 mmol, 1.5 equiv.) and EtOAc (60 mL) were added to a 100 mL RBF fitted with a 
reflux condenser and refluxed at 80 °C for 24h. The reaction mixture was then filtered over 
a frit, concentrated and purified using gradient column chromatography (SiO2, eluent: 
hexanes to 10% ethyl acetate, 90% hexanes) to yield C (407 mg, 41%) as a colorless oil 
which matched previously reported 1H data. 
Procedure 41: Acetylene 3-propionaldehyde 
 
Acetylene D was prepared by bromination of propargyl alcohol as outlined in previous 
work.55 1- bromo-propargyl alcohol (1 equiv.) was then oxidized using IBX (1.2 equiv.) by 
refluxing in ethyl acetate to afford 3-bromopropionaldehyde upon filtration through celite to 
match published information.56 This was used crude as a solution in ethyl acetate for the 
Diels-Alder reaction. 
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Procedure 42: Acetylene 3-chloropropionaldehyde 
 
Acetylene E was prepared by chlorination of propargyl alcohol diethyl acetal as outlined 
by name.57 1-chloro-propargyl aldehyde diethyl acetal (3.96 g) and 4M H2SO4 (20 mL) were 
added to a RBF attached to a short-path vigreaux distillation apparatus. The solution was 
refluxed and 3-chloropropionaldehyde was collected in the receiving flask at -78 °C as a 
solution in ethanol. This was used crude in ethanol for the Diels-Alder reaction. 
Procedure 43: Compound 92 
   
Sulfone 91 (50 mg, 0.25 mmol, 1 equiv.) and the potassium ethyl xanthogenate salt (48 
mg, 0.27 mmol, 1.1 equiv.) were added to a round bottom flask fitted with a stir bar open to 
air. The solids were then diluted in CHCl3 (5 mL, 0.05 M) and stirring of the suspension was 
started. Acetic acid (0.14 mL, 2.5 mmol, 10 equiv.) was then added dropwise and the 
reaction was stirred until reaction completion. This usually takes about 5-20 minutes. The 
reaction mixture was diluted with water and the organic products were extracted with CHCl3 
(3 x 5 mL). The combined organic layers were then dried over Na2SO4 and filtered and 
concentrated. The products were then purified by column chromatography (SiO2, eluent: 
hexanes to 6% ethyl acetate, 94% hexanes) to yield 92 as a mixture of cis- and trans-
isomers of the xanthate reagent cis-92 and trans-92 (2:1 ratio in crude mixture, 16 mg, 33% 
yield). Note: When acetic acid was added first, the xanthate acetal 93 was formed. When >2 
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equivalents of the potassium ethyl xanthogenate salt were added, the double substitution 
product 94 was formed as the predominant product, especially after prolonged stirring. 
cis-92: 1H NMR (500 MHz, CDCl3) δ 8.49 (d, 1H, J = 7.6 Hz), 7.25 (d, 1H, J = 7.6 Hz), 
4.78 (q, 2H, J = 7.1 Hz), 1.50 (t, 3H, J = 7.1 Hz.; Rf=0.75 (10% ethyl acetate, 90% hexanes). 
trans-92: 1H NMR (500 MHz, CDCl3) δ 8.84 (d, 1H, J = 13.8 Hz), 7.27 (d, 1H, J = 13.8 
Hz), 4.78 (q, 2H, J = 7.1 Hz), 1.50 (t, 3H, J = 7.1 Hz).; Rf=0.5 (10% ethyl acetate, 90% 
hexanes). 
cis- and trans-92: 13C NMR (151 MHz, CDCl3) δ 207.93, 203.34, 139.50, 138.99, 
134.66, 133.21, 72.15, 72.09, 13.67, 13.65. 
acetal 93: 1H NMR (500 MHz, CDCl3) δ 6.10 (t, 1H, J = 6.0 Hz), 5.05 (d, 2H, J = 6.0 
Hz), 4.68 (q, 4H, J = 7.1 Hz), 1.45 (t, 6H, J = 7.1 Hz).; 13C NMR (151 MHz, CDCl3) δ 
209.56, 71.16, 52.32, 13.68.; Rf=0.625 (10% ethyl acetate, 90% hexanes). 
double substation product 94: 1H NMR (500 MHz, CDCl3) δ 8.02-7.97 (m, 2H), 7.68 
(ddt, 1H, J = 8.0, 7.0, 1.2 Hz), 7.56 (m, 2H), 7.62-7.47 (m, 2H), 5.66 (dd, 1H, J = 11.4, 3.7 
Hz), 4.67-4.55 (m, 2H), 4.58-4.41 (m, 3H), 4.18 (dd, 1H, J = 14.6, 3.8 Hz), 3.33 (dd, 1H, J 
= 14.6, 11.4 Hz), 1.40 (t, 3H, J = 7.1 Hz), 1.33 (t, 3H, J = 7.1 Hz).; 13C NMR (151 MHz, 
CDCl3) δ 212.21, 209.06, 136.50, 134.41, 129.84, 129.10, 71.62, 71.00, 70.61, 33.86, 13.70, 
13.58.; Rf=0.25 (10% ethyl acetate, 90% hexanes). 
Procedure 44: Compound 96 
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Sulfone 91 (9.1 g, 45 mmol, 1 equiv.) was added to a round bottom flask with a stir bar 
and diluted in CHCl3 (350 mL, 0.05 M). Stirring was started and sodium 
dimethyldithiocarbamate hydrate (7.12 g, 50 mmol, 1.1 equiv.) was added to the solution 
portionwise. The reaction was stirred open to air at room temperature until completion by 
TLC. This usually took about 2-6 hours and was not changed when stirred for longer periods 
of time. The reaction mixture was then diluted with water and the organic product was 
extracted with CHCl3 (3 x 5 mL). The combined organic layers were then dried over 
Na2SO4 and filtered and concentrated. The products were then purified by column 
chromatography (SiO2, eluent: hexanes to 30% ethyl acetate, 70% hexanes) to yield 92 as a 
mixture of cis- and trans-isomers of the xanthate reagent cis-92 and trans-92 (~4:1 to ~10:1, 
1.99 g, 23% yield). 
cis-96: 1H NMR (500 MHz, CDCl3) δ 9.09 (d, 1H, J = 7.8 Hz), 7.33 (d, 1H, J = 7.8 Hz), 
3.63 (s, 3H), 3.55 (s, 3H.; 13C NMR (151 MHz, CDCl3) δ 190.57, 141.14, 133.23, 129.92, 
46.99, 41.76.; Rf=0.45 (33% ethyl acetate, 67% hexanes). 
Procedure 45: Compound 98 
 
A 10 mL RBF was flame-dried under a nitrogen balloon and the solid tetramic acid 97 
(20 mg, 0.091 mmol, 1 equiv.) was added to the flask. Dry dichloromethane was then added 
to the flask and was cooled to -78 °C. Upon cooling, Et3N (25 µL, 0.182 mmol, 2 equiv.) 
was added dropwise to the flask and stirred for 10 minutes. TMSOTf (35 µL, 0.182 mmol, 2 
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equiv.) was then added to the reaction mixture and allowed to stir for 15 minutes. The vinyl 
nitro xanthate reagent 92 (mixture of isomers in dry CH2Cl2) was then added dropwise to 
the reaction and the resultant mixture was allowed to warm to rt over 4h upon completion by 
TLC. The reaction mixture was quenched with saturated NH4Cl and the products (mixture 
of diastereomers) were extracted using dichloromethane (3 x 5 mL). The combined organics 
were then dried over Na2SO4, filtered then concentrated. The crude mixture was purified by 
column chromatography (SiO2, eluent: hexanes to 70% ethyl acetate, 30% hexanes) to yield 
98 as a mixture of diastereomers (18 mg, 48% yield). 
98: 1H NMR: not reporting data.; 13C NMR: no data collected.; Rf=0.33 (60% ethyl 
acetate, 40% hexanes). 
Procedure 46: Compound 99 
 
The conjugate addition product 98 (18 mg, 0.044 mmol, 1 equiv., mixture of 
diastereomers) was added to a sealed tube and diluted in benzene (3 mL, 0.015 M). The 
flask was charged with a stir bar and lauroyl peroxide (51 mg, 0.13 mmol, 3 equiv.) and 
sealed with a Teflon lined cap. The reaction vessel was then heated for 2h at 80 °C. After 
the reaction was complete, the solution was concentrated and purified by by column 
chromatography (SiO2, eluent: hexanes to 75% ethyl acetate, 25% hexanes) to yield 99 (6 
mg, 56% yield). 
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99: 1H NMR (500 MHz, CDCl3) δ 7.36-7.32 (m, 2H), 6.90-6.86 (m, 2H), 5.58 (ddd, 1H, 
J = 17.1, 10.1, 7.8 Hz), 5.41-5.30 (m, 2H), 5.17 (d, 1H, J = 0.8 Hz), 4.90 (dd, 1H, J = 7.8, 
0.8 Hz), 3.84 (s, 3H), 3.78 (s, 3H).; 13C NMR: no data collected.; Rf=0.17 (50% ethyl 
acetate, 50% hexanes). 
Procedure 47: Compound 101 
 
A 10 mL RBF was flame dried and a nitrogen balloon was attached. The solid tetronic 
acid 101 (11.7 mg, 0.103 mmol, 1 equiv.) was added to the flask and diluted in dry THF (5 
mL, 0.02 M). The mixture was then cooled to -78 °C and n-BuLi (0.067 mL, 0.114 mmol, 
1.1 equiv.) was then added dropwise. The resultant solution was stirred for 10 minutes. At 
this time, the xanthate reagent 92 (40 mg, 0.207 mmol, 2 equiv., mixture of isomers in dry 
THF) was added dropwise and the solution turned a dark orange color. The reaction mixture 
was quenched upon completion by TLC (50 minutes) with saturated NH4Cl and extracted 
with EtOAc (3 x 5 mL). The combined organic layers were dried over Na2SO4, filtered and 
concentrated. The reaction mixture was purified by column chromatography (SiO2, eluent: 
hexanes to 35% ethyl acetate, 65% hexanes) to yield the conjugate addition product, 101 
CA product (14 mg, 45% yield). 
101 CA product: 1H NMR (500 MHz, CDCl3) spectrum included, no values reported.; 
13C NMR: no data collected.; Rf=0.17 (33% ethyl acetate, 67% hexanes). 
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The purified product 101 CA product (14 mg, 0.045 mmol, 1 equiv.) was then 
dissolved in benzene (2.5 mL, 0.02 M) and added to a vial fitted with a stir bar. Lauroyl 
peroxide (54 mg, 0.14 mmol, 3 equiv.) was then added to the reaction vial and it was sealed 
with a Teflon lined cap and heated at 80 °C for 2h. The reaction mixture was concentrated 
and purified by column chromatography (SiO2, eluent: hexanes to 40% ethyl acetate, 60% 
hexanes) to yield 101 (6 mg, 95% yield). 
101: 1H NMR (500 MHz, CDCl3) δ 5.75 (m, 1H), 5.57 (d, 1H), 5.17 (d, 1H), 5.38 (d, 
1H), 5.05 (s, 1H), 3.87 (s, 3H.; 13C NMR (151 MHz, CDCl3) δ 181.04, 172.15, 130.90, 
120.48, 88.16, 79.38, 59.57, 29.68.; Rf=0.3 (33% ethyl acetate, 67% hexanes). 
Procedure 48: Compound 103 
 
A 10 mL RBF was flame dried and a nitrogen balloon was attached. The C-3 methyl 
tetronic acid 102 (6.6 mg, 0.517 mmol, 1 equiv.) was added to the flask and diluted in dry 
THF (5 mL, 0.01 M). The mixture was then cooled to -78 °C and n-BuLi (0.032 mL, 0.054 
mmol, 1.05 equiv.) was then added dropwise. The resultant solution was stirred for 10 
minutes. At this time, the xanthate reagent 92 (20 mg, 0.103 mmol, 2 equiv., mixture of 
isomers in dry THF) was added dropwise and the solution turned a dark orange color. The 
reaction mixture was quenched upon completion by TLC (50 minutes) with saturated NH4Cl 
and extracted with EtOAc (3 x 5 mL). The combined organic layers were dried over 
Na2SO4, filtered and concentrated. The reaction mixture was purified by column 
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chromatography (SiO2, eluent: hexanes to 35% ethyl acetate, 65% hexanes) to yield 102 CA 
product (7 mg, 42% yield). 
102 CA product: 1H NMR (500 MHz, CDCl3): spectrum included, values not reported.; 
13C NMR: no data collected.; Rf=0.40 (50% ethyl acetate, 50% hexanes). 
The purified conjugate addition product, 103 CA product (7 mg, 0.022 mmol, 1 equiv.) 
was then dissolved in benzene (2 mL, 0.01 M) and added to a vial fitted with a stir bar. 
Lauroyl peroxide (26 mg, 0.065 mmol, 3 equiv.) was then added to the reaction vial and it 
was sealed with a Teflon lined cap and heated at 80 °C for 2h. The reaction mixture was 
concentrated and purified by column chromatography (SiO2, eluent: hexanes to 45% ethyl 
acetate, 55% hexanes) to yield 103 (3 mg, 89% yield). 
103: 1H NMR (600 MHz, CDCl3) δ 5.90 (dd, 1H), 5.43 (dd, 1H), 5.22 (dd, 1H), 4.98 (s, 
1H), 3.92 (s, 3H), 1.56 (s, 3H).; 13C NMR: no data collected.; Rf=0.45 (50% ethyl acetate, 
50% hexanes). 
Procedure 49: Compound 106 
 
A 50 mL round bottom flask was flame dried with 4Å MS and put under a nitrogen 
balloon. The known disulfide 105 (360 mg, 1.485 mmol, 1 equiv.) was then added as a 
solution in THF (15 mL, 0.1 M) and the mixture was cooled to -78 °C. After cooling for 10 
minutes, vinyl magnesium chloride (0.78 mL, 1.485 mmol, 1 equiv., 1.9M in THF) was then 
added dropwise to the solution and it was allowed to warm to rt over 5h. After stirring at rt 
O
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for 15 minutes, the reaction mixture was quenched with 1M HCl to yield the vinylated ethyl 
xanthate 106 in quantitative yield without purification. 
106: 1H NMR (500 MHz, CDCl3) δ 6.99 (dd, 1H, J = 17.3, 10.0 Hz), 5.52 (d, 1H, J = 
10.0 Hz), 5.50 (d, 1H, J = 17.3 Hz), 4.67 (q, 2H, J = 7.3 Hz), 1.43 (t, 3H, J = 7.3 Hz). 
Procedure 50: Compound 108 
 
A 50 mL round bottom flask was flame dried with 4Å MS and put under a nitrogen 
balloon. The known disulfide 107 (70 mg, 0.29 mmol, 1 equiv.) was then added as a 
solution in THF (5 mL, 0.06 M) and the mixture was cooled to -78 °C. After cooling for 10 
minutes, vinyl magnesium chloride (0.84 mL, 1.45 mmol, 5 equiv., 1.9M in THF) was then 
added dropwise to the solution and it was allowed to warm to rt over 1h. After stirring at rt 
for 15 minutes, the reaction mixture was quenched with 1M HCl to yield the vinylated 
dimethyldithiocarbamate 108 in quantitative yield without purification. 
108: 1H NMR (600 MHz, CDCl3) δ 7.16 (dd, 1H), 5.57 (dd, 1H), 3.56 (s, 3H), 3.38 (s, 
3H). 
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